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Preface 
 
In this report we present a series of prospective studies to validate the use of 
ultrasound in assessing caesarean section (CS) scars in pregnant women. This 
subject is becoming increasingly important in the modern obstetric practice. 
Therefore, we developed a standardised approach to evaluate the scar by 
ultrasound scan and we tested its reproducibility throughout the course of 
pregnancy. In addition, we followed the natural history of the scar in the pregnant 
state and investigated the association between scar morphology and early 
pregnancy implantation, placental development and subsequent performance in 
labour.  	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Abbreviations 
 
BMI    Body mass index 
CS    Caesarean section 
CSP    Caesarean scar pregnancy 
CI    Confidence interval 
2D    Two dimensional, B-mode ultrasound 
ERCD   Elective repeats caesarean delivery 
EmRCD   Emergency repeats caesarean delivery 
EPAU   Early pregnancy assessment unit 
GIS    Gel installation sonography 
IOV    Intraobserver/ interobserver variability 
ICC    Intraclass correlation coefficient 
LUS    Lower uterine segment 
MSS    Mean scar size 
PPH    Post partum haemorrhage  
PBAC     Pictoral blood loss assessment chart 
RMT    Residual myometrial thickness 
SCSH   Saline contrast sonohysterography 
SVD    Spontaneous vaginal delivery 
SD    Standard deviation 
SIS     Saline infusion sonography 
TAS     Transabdominal Sonography 
TVS     Transvaginal Sonography 
UV fold   Uterovesical fold 
VBAC   Vaginal birth after caesarean section 	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Abstract 
Incomplete healing of CS scars has become a recognised sequel to this operation, 
and is associated with complications in later pregnancies. These can include 
caesarean scar pregnancy (CSP), a morbidly adherent placenta, scar dehiscence 
or rupture. To date there is uncertainty relating to the recognition of poor scar 
healing and the factors that lead to it. In recent years, there has been an increase in 
studies using ultrasound imaging to describe scars as deficient, or incompletely 
healed. However, these studies were carried out in the non-pregnant state, with a 
paucity of data to associate the described morphology of these scars to the 
functional integrity of the lower uterine segment (LUS) in subsequent pregnancy, or 
the actual performance in labour.  
 
We hypothesised that unenhanced transvaginal sonography (TVS) is a valid and 
reproducible method of assessing CS scars in pregnant women, and it can provide 
relevant clinical information on the effects these scars might have in pregnancy. To 
investigate the validity of TVS as the imaging modality of choice, we proposed a 
standardised approach for obtaining scar measurements. Furthermore we 
established a consensus agreement for nomenclature and methodology in imaging 
and reporting CS scars. We tested the reproducibility of the agreed methods 
throughout the course of pregnancy and our data showed that TVS could reliably 
delineate CS scar with good interobserver and intraobserver variability (IOV).  
 
We also investigated the influence of different scar dimensions on pregnant women 
from early pregnancy, during placental development, throughout the antenatal 
course and at delivery in terms of implantation sites, vaginal bleeding, and placental 
location, as well as the effects of scar changes on the final scar appearance at 
repeat CS, or during trials of vaginal birth after caesarean section (VBAC). Our data 
demonstrated that women who attended the early pregnancy assessment unit 
(EPAU) with a previous history of CS had more vaginal bleeding but similar 
spontaneous miscarriage rates in comparison to women without a history of CS. 
However, the implantation sites in the scarred uterus were significantly different 
from the non-scarred uterus. In the second trimester there were also significant 
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differences in placental location. In the CS group there were more posterior and 
fewer fundal placentas than in the control group.   
 
We found that CS scars underwent significant changes to their shape and 
dimensions from the second trimester onwards. These scars were affected by the 
physical expansion of the gravid uterus and expanded accordingly in a cephalo-
caudal pattern.  
 
Finally, we have demonstrated that certain scar measurements in the second 
trimester were associated with particular scar appearance at repeat caesarean 
delivery, and potentially predicted the likelihood of uterine scar rupture. We 
integrated this information and developed a prediction model on the likelihood of 
achieving successful VBAC from the earlier stages of pregnancy. 
 
In conclusion our data confirms that CS scar can be reliably assessed by 
ultrasound scan, and certain scar features are associated with complications that 
can be anticipated from as early as 6 weeks gestation. The results of our study 
provide important new information, which if validated externally may have 
significant bearing on our understanding of the impact of CS on the uterus, and the 
management of women planning to attempt a vaginal delivery after a previous CS.  	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Chapter 1: Introduction 	  
Caesarean section is one of the most frequent abdominal surgical operations 
performed in the UK and worldwide	   1. The CS rate increased from 12% to 29% 
between 1990 and 2008	   2 in the United Kingdom and from 21.2% to 30.1% in the 
United States 3. The increasing CS rate and its associated complications has 
stimulated an interest in the behaviour of CS scars and their associated potential 
morbidity amongst health professionals. The incidence of uterine rupture in trials of 
VBAC has remained static with a frequency estimated at between 0.2% and 3.8% 4. 
However, the future performance of the uterus after CS is still an underexplored area 
of research, of particular interest is the effect of caesarean scar on pregnancy 
implantation, and the development of protocols for early prediction of successful 
trials of VBAC.  
 
In the past decade, we have seen a rapid development in imaging, and ultrasound 
scanning in particular has flourished in the field of obstetrics and gynaecology with 
regards to new developments in the diagnosis of polycystic ovaries and various 
congenital fetal abnormalities. More recently, ultrasound scan has increasingly been 
used as the imaging modality of choice in assessing CS scars. Several reports have 
emphasised the importance of accurate description of CS scars. However, these 
studies did not translate into clinical application as they were all carried out on non-
pregnant women. The appearance of the CS scar using ultrasound may be relevant, 
but there is limited evidence to relate the scar appearances with function. In addition, 
there are concerns about the incidence of implantation within the scar as well as the 
association between a scarred uterus and abnormal uterine bleeding and subfertility	  
5 6.   
In this research work we have aimed to summarise the published literature on this 
condition. Furthermore, we have proposed an approach to evaluating CS scars and 
measuring them using TVS. In this way we hope to move towards agreement on 
standardising nomenclature so that useful comparisons can be made between any 
future research studies in this area. 
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    1.1   Mechanism of caesarean scar healing in the uterus  
 
Some lower uterine segment wounds heal incompletely and can in a subsequent 
pregnancy and labour lead to rupture or dehiscence of the uterus 7. Classically, any 
wound healing process goes through phases of hemostasis, inflammation, 
proliferation and remodelling. Caesarean section wound heals by a similar and well-
orchestrated cascade	   4. However, the remodelling phase is slightly different from 
the usual cascade. In essence, the fibroblasts and smooth muscle elements 
forming in this phase depend on additional factors: the myometrial layer being 
sutured, the type of suturing whether it is continuous or interrupted and accurate 
approximation across the entire uterine layers 8.  
 
It is believed that proper healing through any smooth muscle incision takes place by 
involving connective and scar tissues, together with the regeneration of smooth 
muscle fibres 9. Each of these elements contributes to this process to a different 
extent. Potter (1954) demonstrated that when wound coaptation is not complicated 
by infection, ischemia or foreign body reaction, healing takes place with minimum of 
connective tissue involvement 8. Moreover, his histological examination of many 
caesarean scars showed that the best union of myometrial edges occurred in the 
inner two thirds of the wall. This area fell into automatic opposition after applying 
accurate tissue approximation. In most cases, there was little or no noticeable 
inversion at the endometrial surface. Furthermore, when an improved closure 
technique was applied by following the accurate tissue approximation described 
above, a bridging of regenerated smooth muscle fibres across the old scar was 
seen, predominating over the connective tissue element. This technique resulted in 
less retraction, less connective tissue and more regeneration of smooth muscle 
fibres. Hess (1953) showed that a superior healing outcome could be obtained 
when applying interrupted sutures to approximate the myometrium, and that the 
serosa should be closed using separate sutures 10. He undertook microscopic 
examination of all of his caesarean scars, and confirmed that healing contained 
mainly fibrous tissue in lower segment incisions, while in wounds involving the 
upper segment, smooth muscle fibres were more abundant, hence his 
recommendations for more accurate tissue approximation in the former. He also 
	   10	  
described two pathophysiologies relating to healing in scarred uteri. These were 
regeneration of smooth muscles and proliferation of fibrous tissues and concluded 
the quality of healing is dependant on which of these pathophysiologies 
predominates. In addition there are mechanical factors associated with the healing 
process in the wounded uterus. These factors are not encountered with wounds in 
other parts of the body. Before reapproximation of the edges, and following 
extraction of the fetus, contraction of the incision begins. This is further augmented 
by the action of oxytocic agents employed, whilst suturing takes place, the uterine 
body and the incision will have reduced to more than half their original size. 
Interestingly, transverse incisions in the lower segment may undergo less rapid 
contraction due to the different tensile strength of the lower uterine segment, and 
whether CS is performed after the onset of labour when the lower segment 
becomes thin. This in theory could be one of the factors contributing to poor lower 
segment scar healing. During the course of a subsequent pregnancy, the growth 
response of muscle fibres occurs with elongation and altered consistency in each 
individual cell, whilst the area of scar tissue remains relatively static	  10. Growth and 
expansion during pregnancy mainly involve the adjacent myometrium, with no 
appreciable gross change in the fibrous tissue component of the scar. 
 
On the other hand, numerous authors have emphasised the importance of 
operative method and suturing technique as the most important factors in wound 
healing	  1	  7	  11	  8. Over the last 50 years, more than 45 published papers reported on 
the different methods of closing CS scars. There are different opinions as to the 
optimum suture type, the number of sutured layers and the suturing technique. The 
most optimum method remains illusive. Closure techniques varied between single 
and double-layer; both have been criticised in terms of achieving reasonable 
outcomes. It has been suggested continuous suturing of the uterus reduces the 
blood supply and loosens as soon as the uterus involutes, hence failing to maintain 
opposition of the wound edges	   12. Interrupted sutures on the other hand are 
believed to limit formation of haematoma, and to give better anatomic results 13. 
 
Poidevin (1961) highlighted the relationship between large scar defects and the 
suturing technique employed 14. However, Zilberman (1968) found no correlation 
between indications, type of operation, postoperative course and the type of uterine 
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defect found 9. Yazicioglu (2006) randomly assigned 78 primiparous women into 
two different methods of uterine closure, full-thickness (including the decidual layer) 
and partial thickness (excluding the decidua), and followed the uterine healing by 
ultrasonography six weeks postoperatively. Wedge-shaped defects were detected 
on ultrasound scan in 44% of the full thickness group, and in 68% of the split 
thickness group. However, no significant difference between the two groups was 
found in terms of gestational age, parity, total blood loss and anterior and posterior 
uterine wall thickness 1.  
 
Hamar (2007) has also conducted a randomised blinded trial on two different types 
of uterine closure, one-layer versus two-layer closure, at caesarean section. Fifteen 
primiparous women were assigned to each group, and underwent ultrasound 
surveillance of the uterine scar and thickness of the lower segment at zero hours as 
a baseline, and at 48 hours, 2 weeks and 6 weeks postpartum. Again, there was no 
statistically significant difference in the myometrial scar thickness between groups 
at baseline, or at any of the follow-up evaluations. However, an initial five to six-fold 
increase in uterine scar thickness was observed in both groups, followed by a 
gradual decrease; the 6-week measurements were still thicker than the baseline. 
This suggests that uterine scar thickness is unaffected by the number of layers 
used for mass closure of uterine wounds 7.  
 
Waniorek (1967) conducted a similar study to examine the relationship between 
type of scar deformity and the suturing method used. He performed hysterographic 
examination on 270 patients who had previously undergone CS, and evaluated the 
scar on the basis of depth, shape and size. He showed the severity of scar 
deficiency was in direct proportion to the number of operations performed. He found 
dye penetration deep into the wall in two cases, where in both; inclusion of the 
decidua in the suture material was clearly recorded in the operative notes. He 
concluded that the x-ray images that demonstrated good healing were obtained 
when a single layer of interrupted suture was applied through the myometrium and 
when the decidual exclusion approach was adopted 15. 
 
The recent CAESAR trial investigated the effect of different surgical techniques on 
maternal infectious morbidity and did not look at the long-term outcomes i.e. the 
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functional integrity of the uterus during subsequent pregnancies 16. While 96% of 
UK obstetricians use double-layer closure of the uterus, the results of the United 
Kingdom national survey of the current suturing techniques concluded there is an 
urgent need for future research to evaluate many aspects of CS operations on 
substantive short and long-term outcomes 17.  
1.2   Imaging uterine scars 	  
Improvements in imaging have facilitated the evaluation of CS scars both prior to 
and during pregnancy. A wedge shaped cystic or hypoechoic distortion in the scar in 
the non-pregnant state is a well-described feature and has been reported in the 
literature using various imaging modalities	   1. It was first described using 
hysterosalpingography in 1961	   7, transabdominal sonography (TAS) in 1982	   18 and 
with TVS in 1990	   19. Poidevin (1961) performed hysterographic examination on 43 
women six months after CS. He described a typical small wedge-shaped 
morphological “defect” in 27 patients, which he believed was an indication of healing 
and considered this safe for vaginal delivery in the future. He further proposed that a 
six month wait was necessary before hysterography, as an earlier examination may 
reveal no deformity owing to wound oedema	  14. Interestingly, this fact was confirmed 
35 years later. Dicle (1997) examined the healing period of the myometrium after CS 
using magnetic resonance imaging. They concluded that myometrial scar tissue 
takes at least three months to form and that complete involution and recovery of the 
zonal anatomy does not occur until six months later	  20. Burger (1982) performed TAS 
on 48 women who had undergone CS. They described a sonolucent area, with 
varying degrees of echogenicity, at the wound site between the anterior wall and 
cavity of the uterus. This pattern was found in 15 out of the 48 patients involved in 
the study, and was classified as an incompletely healed uterine scar 18. Once again 
the data to link the appearance of the scar to the functional integrity of the uterus 
was not reported.  
 
Transvaginal sonography has since offered a further tool for observing the uterine 
scar after CS. Chen (1990) described a wedge-shaped hypoechoic area at the CS 
wound site, easily distinguishable from the neighbouring part of the lower uterine 
segment. He used Doppler to show that the scar is relatively avascular. He found 
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that the longer the time elapsed after surgery the smaller the wedge-shaped “defect” 
became	   19. Monteagudo (2001) at a later stage introduced the word “niche”. She 
described the niche using ultrasound as a triangular anechoic area at the presumed 
site of CS incision	  21.   
 
There are now many studies describing the morphological features of CS scars, and 
the methods used in reporting the ultrasound findings are in the majority of studies 
clear. However, important questions remain to be answered. Principal among these 
is whether a scar classified as deficient using ultrasound leads to an increased risk 
of failed VBAC or uterine rupture in labour, and if it is associated with other 
complications such as menstrual problems, subfertility and scar pregnancy. A recent 
study by Osser V (2010) has suggested a possible relationship between the non-
pregnant appearance of a CS scar and scar performance in a subsequent 
pregnancy. However the number of cases included in the study was too small to 
draw definitive conclusions 22. 
 
1.2.1   Ultrasonography to assess caesarean section scar 
morphology 	  
Ultrasonography has been used to evaluate CS scars in late pregnancy	   23. 
Numerous authors attempted to describe the LUS using both two and three-
dimensional ultrasound (2D, 3D), and compared the two methods in terms of 
reliability, reproducibility and cost-effectiveness. Jastrow (2006) conducted a study to 
assess the reliability of 2D, 3D, TAS and TVS in measuring the LUS and CS scar in 
late pregnancy. They included 129 women with at least one previous CS who had 
singleton pregnancies, a cephalic presentation, and were between 36 and 39 weeks 
gestation. The authors concluded that TVS was more reliable for measuring the 
thickness of the LUS than transabdominal approach, with less than 1mm difference 
in the intra and interobserver variability 24. Martin (2009) confirmed these findings in 
a similar study	  25.  
 
CS scar morphology and dimensions have been described in different studies, and 
different grades of apparent deficiency reported according to the subjective 
impression of the morphological “defect” occupied by the scar. Bij de Vaate (2010) 
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demonstrated scar length and depth in the sagittal plane using TVS with gel 
enhancement, as well as scar volume by 3D ultrasound	   5. Osser (2010) applied 
similar methods. She used saline contrast sonohysterography (SCSH) and found 
delineating the scar in the transverse plane to be technically difficult, and concluded 
that SCSH is not a reliable method to assess the scar width	   26. Both these studies 
relied on subjective evaluation of the scar to classify them as small or large, although 
the authors subsequently suggested an objective assessment for any future studies.   
 
Subjective impression by expert operators is a legitimate approach to classification 
using ultrasound, an example being the characterization of ovarian pathology	   27. 
However, the experience required to do this is not easy to gain, and so a more 
objective quantification is needed if the assessment of CS scars is to become 
generally reproducible.  
 
The use of 3D ultrasound has been reported to improve the inter-observer reliability 
of CS scar measurements in pregnant women	  25. However, its use requires specific 
training, a longer examination time and ultrasound machines with facility for 3D 
applications. Contrary to what is often stated, 3D ultrasound is not without limitations	  28. One of the problems encountered when it comes to assessing CS scars by 3D 
ultrasound is the lack of good tissue contrast, which is helpful for optimal 3D 
examination of the scar. However some scar indentations contain blood or fluid, 
which may act as a contrast agent. In the non-pregnant uterus, the instillation of 
saline or gel may achieve a similar effect	  5. An important advantage of 3D ultrasound 
over conventional 2D imaging is its ability to reconstruct and display chosen sections 
within the volume dataset.  In particular, examination of the scar in the coronal plane 
provides additional information, which cannot be obtained using 2D ultrasound. In 
addition, Virtual Organ Computer Aided Analysis (VOCAL) and XI VOCAL 
technology enable volume measurements	  28	  29.  
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1.2.2   Prevalence of ‘defective’ CS scars seen using 
ultrasonography 	  
The prevalence of CS scar morphological “abnormalities” has been studied in non-
pregnant women using TVS and/or SCSH in seven publications in English language 
journals over the past 10 years	  4	  5	   30	   31	   32	   33	   34. The prevalence of CS scars with an 
apparent “defect” ranged from 19-69% (Table 1). Different methods of classifying CS 
scars have been applied, based on the dimensions of the scar and its relation to the 
internal cervical os and the uterine fundus. In all the studies cited, a scar “defect” or 
“niche” was defined by the presence of a hypoechogenic area within the 
myometrium of the lower uterine segment, at the site of previous CS	   18. Despite 
similar imaging protocols, there was no agreement between the seven studies 
regarding the definition of apparent scar defects, and to the best of our knowledge, 
there is paucity of studies that describe CS scar assessments across all trimesters of 
pregnancy. The relative lack of data on this important subject is a limiting factor in 
establishing the real prevalence of different morphological subgroups of CS scars. 
 
In the non-pregnant uterus, apparent scar “defects” is more likely to appear larger 
and have clearer margins when saline infusion sonography (SIS)	  12 or gel instillation 
sonography (GIS) is used	  5. We agree that apparent prevalence of any scar “defects” 
increases if SIS or GIS is used compared to 2D ultrasound. However, the increased 
uterine pressure associated with this procedure may exaggerate the size of any scar 
present. There is disagreement about the value of SIS in this context. Monteagudo 
(2001) concluded that ultrasound examination of CS scars is not possible without 
saline infusion enhancement	   21, whilst Ofili-Yebovi (2008) suggested that saline 
infusion may be associated with unnecessary risks i.e. infection, is not cost-effective 
and of limited value	   4, although the risks of SIS seem to be rather low in reality 31. 
More recently, no complications were encountered using SIS or GIS to examine CS 
scars	  12	  5. Whatever method is used, it is clear that there must be consistency if data 
are to be comparable as different results are likely with and without SIS.   	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Study  
 
N 
 
Scar definition 
 
Methods 
 
% of CS 
scars 
 
% of 
large 
scars 
 
Type of study 
 
Bij de 
Vaate  
2011  
 
 
 
 
225 
 
 
Anechoic area at 
the site of the 
caesarean scar 
‘niche’ with a 
depth of at least 
1 mm 
• Scar depth  
• Residual 
myometrium 
• Scar volume on XI 
VOCAL 
• With and without 
gel installation  
24% on TV 
ultrasound 
56% with gel 
installation 
 
 
 
 
NP* 
 
Observational 
prospective 
cohort  
 
Vikhareva 
Osser  
2009  
 
 
 
 
 
 
 
 
162 
 
Any indentation 
at the scar area, 
however small 
• Subjective 
evaluation 
• Thickness of 
remaining 
myometrium above 
scar 
• Thickness of the 
myometrium next 
and cranial to the 
defect 
 
 
69% 
 
 
42% 
 
Prospective 
cohort 
 
 
Wang  
2009  
 
 
 
 
 
4250 
Filling defect 
within the 
myometrium of 
the lower uterine 
segment, at the 
presumed site of 
previous LSCS 
• Scar width 
• Scar depth 
• Thickness of the 
residual 
myometrium 
 
 
6.9% 
 
 
6.3% 
 
Cross-
sectional  
 
Ofili-
Yebovi  
2008  
 
 
 
 
 
 
 
324 
 
Any detectable 
myometrial 
thinning at the 
LSCS site.  
• Distance between 
uterine fundus and 
internal os  
• Myometrial 
thickness at the 
depth of the scar 
• Myometrial 
thickness at the 
adjacent unaffected 
myometrium 
 
 
19% 
 
 
10% 
 
Prospective 
cohort 
 
Valenzano  
2006 
 
 
 
116 
 
Triangular 
anechoic area at 
the presumed 
site of incision 
(niche) 
 
 
Presence or 
absence of the scar 
 
 
59.5% 
 
 
NP 
 
Retrospective 
observational 
case control 
 
Regnard  
2004 
 
 
 
 
33 
 
Triangular 
anechoic area at 
the presumed 
site of incision 
(niche) 
 
• Scar depth 
• Thickness of 
residual 
myometrium 
• Thickness of 
cranial myometrium 
• With saline contrast 
enhancement  
 
 
 
60% 
 
 
NP 
 
Prospective 
cohort 
 
Armstrong  
2003  
 
 
32 
 
Any detectable 
fluid within the 
scar 
 
• Presence or 
absence of the scar 
 
 
42% 
 
NP 
 
Prospective 
cohort 
* NP: Not performed; LSCS= lower segment caesarean section 
Table 1: Prevalence of ‘abnormal’ CS scars seen by TVS 
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1.3   Caesarean section scar and early pregnancy 	  
The number of caesarean sections being performed has increased, and accordingly 
the long-term impact of this operation on reproductive outcomes is a concern 35. To 
date, there has been little discussion regarding the influence of CS scars on early 
pregnancy events such as implantation and spontaneous miscarriage. Most studies 
have included very small numbers of patients with no definite conclusions	  36. In 1996 
Hemminki and colleagues reviewed the impact of CS on future reproduction	   36, and 
concluded that CS is a risk factor for lowered fertility and early pregnancy loss, 
including ectopic pregnancy and spontaneous miscarriage. However, the clinical 
relevance of the relationship between implantation and CS scars visualised using 
TVS was not specifically explored in this review or in any study to date.   
 
Spontaneous miscarriage is the most common complication of pregnancy	   37, with 
chromosomal abnormalities associated with increasing maternal age being 
responsible for more than 50% 38. At present, the maternal response to an 
implanting embryo is believed to be the most important factor in determining 
pregnancy outcome. This maternal response is termed decidualization, a process 
that occurs in all species where implantation causes breaching of the luminal 
endometrial epithelium	  39. There is a growing body of evidence to suggest that early 
pregnancy loss is caused by impaired decidualization 37, and it is possible that the 
presence of a CS scar in the uterus may further compromise this process.  Another 
mechanism may be impairment of junctional zone contractility secondary to oxidative 
stress at the site of scarred endometrium 40.  
 
A deleterious effect of the presence of a CS scar on the uterus was further 
supported by Ben-Nagi who suggested there might be a link between altered uterine 
immunobiology, CS and embryo implantation 6. They studied the effect of CS on the 
endometrium in premenopausal women with a history of CS; endometrial samples 
were taken from both the caesarean scar site and posterior uterine wall, and the 
results were compared with samples obtained from the posterior uterine wall in 
women who had spontaneous vaginal deliveries (SVD) only. The most significant 
difference was that fewer leukocytes and less vascularisation were found at the scar 
site than in the endometrium of the unscarred uterus. In addition, they found a delay 
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in endometrial maturation at the scar area, and this delay might have been a result 
of disruption in steroid receptor expression. 
 
A further important consequence of CS is caesarean scar pregnancy. Ash and 
colleagues reported a rise in published articles of CSP, however the true prevalence 
of CSP is still not known	  41. They question whether this apparent increase in number 
is due to the increase of caesarean section deliveries or better recognition of CSP 
with TVS. Distinguishing between CSP, cervical pregnancy and an intrauterine 
gestation sac implanted low in the cavity may be difficult 42. A recent review by 
Timor-Tritsch reported that the diagnosis was missed in 107 out of the 751 cases 
reviewed 43. Just as concerning is the possibility of a false positive diagnosis of CSP, 
leading to the termination of a viable correctly located pregnancy.  
 
In the early pregnancy part of this work we aimed to study the impact of the 
presence of a CS scar on the location of the implantation site, symptoms and risk of 
spontaneous miscarriage for women attending an early pregnancy assessment unit. 
We further aimed to follow up the cases where implantation was close to or crossing 
the scar in order to examine their relationship to the developing placenta and to 
investigate how this could relate to outcome.    
 
1.4   Caesarean section scar and placental development in the 
first and second trimesters 	  
The next phase of pregnancy, when the placenta development occurs, is a complex 
process and the mechanism of placental localisation is not well understood. The 
contact between maternal and fetal tissue is dependent on the cytotrophoblast shell 
of the developing placenta and the decidualising endometrium	   44	   45. This is a 
dynamic phase of the pregnancy as the placenta increases in size and complexity. 
Therefore, a favourable endometrial environment is essential in order to ensure the 
development of an adequate fetal-maternal interface. To date, it is not known if a 
scar on the uterus has any effect on the global endometrial environment and on 
placental location in particular. 
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The frequency of placenta praevia decreases with increasing gestational age 
because of ‘placental migration	   46. This is because the placenta-free uterine wall 
grows faster than placenta-covered areas	   47. The placenta does not actually move, 
but the tissue upon which it is embedded expands, leading to the placenta’s 
appearing to move up and away from the cervix. This process applies in the normal 
intact uterus, but it is not known if the same mechanism occurs as effectively in a 
scarred uterus. 
 
It is interesting to speculate what the mechanism might be for any differences in 
implantation site in the presence of a CS scar. One hypothesis is that the presence 
of a CS scar leads to a change in myometrial contractility; another is that the integrity 
of the myometrial – endometrial junctional zone is compromised. Hence any 
alteration in placental location might provide indirect evidence of a more global 
impact of the presence of a CS scar on uterine function, which may have 
implications for both future fertility and subsequent pregnancies. 
 
Ultrasonography has become the imaging modality of choice for assessing the 
placenta	   48	   49	   50. Although CS is an established risk factor for pathological 
placentation, it is not known if it influences placental location in other ways	   51. A 
previous report based on ultrasound scans carried out at 28 weeks’ gestation 
concluded that the presence of a CS scar has no impact on placental location	   48. 
There have been several studies reporting on differences in placental migration 
according to placental position	  46. However, the results have varied widely. Magann 
(1998) reported that posterior placentae were three times more likely to migrate than 
anterior placentae	   52, but Oppenheimer (2001) reported no difference in migration 
rates between anteriorly and posteriorly situated placentae	   53. Both these studies 
were performed in a small number of women with no history of caesarean delivery. 
Therefore, we aimed to determine whether the presence of a CS scar on the uterus 
leads to a difference in placental location at 11 – 14 weeks’ gestation, and whether 
subsequent placental migration differs in comparison to the uteri of women who have 
not undergone a previous CS. 
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1.5   Caesarean section scar changes in pregnancy- the natural 
history and clinical relevance 
 
Several reports have used ultrasound to describe CS scars 34	   5	   32	   18	   54	   55, however, 
most have been carried out on non-pregnant women and so are difficult to interpret 
in the pregnant state. The appearance of CS scars with ultrasonography may be 
relevant, but there is limited evidence to relate scar appearances with function in a 
future pregnancy. A recent study by Osser (2010) suggested a possible relationship 
between the non-pregnant appearance of a CS scar and scar performance in a 
subsequent pregnancy. However the number of cases included in the study was too 
small to draw definitive conclusions 12. 
	  
It is not known whether a scar classified as “deficient” using ultrasound leads to an 
increased risk of failed VBAC or uterine rupture in labour. Scar “deficiency” or 
presence of a “niche” refers to a hypoechoic segment of varying size. Usually there 
are two segments to a CS scar; the hypoechoic segment (or apparent defect) and 
scar tissue contained in the residual myometrium. This part of the scar can be 
usefully expressed as the residual myometrial thickness (RMT).  
 
Different grades of apparent deficiency have been reported according to the 
subjective impression of the operator in relation to the hypoechoic “apparent defect” 
occupied by either all or part of the scar. However, a more objective quantitative 
approach is desirable if scar assessment is to be reproducible. In addition, several 
authors have attempted to select patients that are more likely to undergo successful 
VBAC using demographic variables as well as the physical examination findings at 
the time of admission for delivery. Growing evidence suggests that complete healing 
of the previous CS scar and the myometrial thickness of the LUS are important 
factors in achieving an uneventful pregnancy outcome 56. Studying the natural 
history of CS scar in pregnancy is important, as certain scar features and how they 
change over the course of pregnancy may provide important information when 
considering either a trial of vaginal delivery or a repeat caesarean delivery. 
Furthermore the incorporation of such ultrasound features into scoring systems or 
models to predict successful VBAC may refine decision making further. Uterine scar 
rupture is a rare event, yet its consequences can be catastrophic.  
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1.6   Ultrasound measurement of the residual myometrial 
thickness as a predictor of uterine scar rupture 	  
Uterine rupture is defined as a full-thickness separation of the uterine wall and the 
overlying serosa	   26. A previous CS is the most important risk factor	   57. The most 
commonly quoted incidence for scar rupture is 0.5%, or one in every 200 women 
who contemplate vaginal delivery after previous CS 58. In spite of the recent 
advances in modern obstetric practice, rupture of the pregnant uterus is still one of 
the most life-threatening complications of pregnancy, and it is associated with high 
rates of maternal morbidity and fetal morbidity and mortality	  59. 	  
 
There are three layers that can be identified in the lower uterine segment in 
pregnancy using B-mode 2D TVS 25: The chorioamniotic membrane with the 
decidualized endometrium, the middle muscular layer and the uterovesical fold 
(peritoneal reflection seen as hyper-echoic line juxtaposed with the muscularis and 
musosa of the bladder). Anatomically, an incision is made in the lower uterine 
segment 2–3cm below the upper edge of the uterovesical fold of peritoneum 60. This 
is especially important when CS is performed at or near full dilatation, when the 
tendency is to enter the uterus too low, due to the stretched and ballooned out lower 
segment. Therefore, the normal LUS can be seen using ultrasonography as a two-
layer structure that consists of a hyperechoic layer (representing the bladder wall) 
and a less echogenic layer representing the myometrium 61 (Image 1).  
 
	  
Image 1: Ultrasound appearance of the myometrium and the bladder wall 
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On the other hand, various methods have been developed to correlate 
measurements of the LUS during pregnancy with the risk of uterine rupture or 
dehiscence 62	   63	   64	   65	   66	   67. In some studies, the investigators measured the entire 
LUS using TAS, whilst in others only the muscular layer was measured using TVS. 
Bujold (2009) conducted a study to establish the validity of sonographic evaluation of 
LUS thickness to predict complete uterine rupture. Full-thickness compared to 
myometrial thickness only was measured by TAS and TVS in 263 pregnant women 
between 35 and 38 weeks gestation. They concluded that a LUS thickness of < 2.5 
mm was associated with a uterine rupture rate of more than 10% with an 
approximate specificity of 90%	   61. Martins and co-workers (2009) concluded in their 
two-observer reliability study that, in the pregnant state, sonographic measurement 
of LUS muscular thickness by TVS appears more reliable than the evaluation of the 
entire LUS thickness by TAS 25. Jastrow and colleagues in their systematic review 
concluded there is a strong association between LUS measurements in pregnancy 
and the risk of uterine scar complications. They proposed this might serve as a 
predictor of uterine rupture. However, no cut-off values have been developed and 
tested, underlining the need for more standardized measurement techniques and 
nomenclature 23. 
 
In conclusion, the measurement of the RMT appears to be the best technique 
available to estimate the risk of uterine rupture, but there is a great heterogeneity in 
the techniques used. It seems necessary to standarise the interventions and their 
teaching prior to extending the use of the RMT measurement to clinical settings 
beyond well-defined research purposes. 
 
1.7   Predicting Vaginal Birth After Caesarean section 	  
The rate of vaginal birth after cesarean section (VBAC) is defined as the number of 
vaginal births to women with one previous cesarean section per 100 such deliveries 
68. Several authors have attempted to predict which patients are more likely to 
undergo successful VBAC by various parameters using clinical history and physical 
examination at the time of admission for delivery 69. Flamm and Geiger attempted to 
develop a scoring system to predict the success of a trial of labour in these patients 
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70, in which they allocated points for maternal age, a history of previous vaginal 
delivery, the indication for the previous caesarean delivery and cervical effacement 
and dilation. When the system was tested, they found that 18% of women had a 
score ≤ 3, corresponding to a lower than 60% likelihood of VBAC, whilst only 29% of 
women in the same group had a score ≥ 6 leading to an estimated 88% or higher 
likelihood of VBAC. It is important to note here that the higher scores in this model 
were applicable to less than 30% of the study population. Dinsmoor and Brock 
tested the Flamm and Geiger model retrospectively on 153 cases, finding that a 
score of ≥ 7 gave a 100% likelihood of VBAC, whilst a score of ≤ 4 reduced the 
chances to 53%. They concluded that an unfavourable score might be helpful when 
counselling patients considering a trial of labour 71. However this system does not 
give a calibrated spectrum of risk and leaves any decision about VBAC until a 
woman is admitted to the delivery room in labour. A better system, which is able to 
predict the success or failure of trial of labour at an earlier stage in pregnancy, is 
required.  
Accurately predicting the outcome of a trial of VBAC is clinically useful, as failure is 
associated with increased maternal and fetal morbidity 67. There is a growing 
evidence to suggest that complete healing of the previous caesarean scar and 
myometrial thickness at the lower uterine segment are important factors in achieving 
vaginal delivery in a subsequent pregnancy 56. Despite this interest in CS scar 
morphology, there have been no longitudinal studies to evaluate the potential 
relationship between scar appearance on ultrasound imaging across all three 
trimesters of pregnancy and pregnancy outcome. Furthermore, no study has 
evaluated whether the rate of change in size of different scar parameters over the 
course of pregnancy may predict the likelihood of successful VBAC.	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Chapter 2: Hypothesis, aims and methods 
 
2.1   Hypothesis 	  
The hypothesis for this research project was: 
“Transvaginal Sonography (TVS) is a valid and reproducible method for assessing 
uterine caesarean section scar in the pregnant state. Standardised assessment of 
scar morphology and dimensions throughout pregnancy can provide important 
clinical information regarding implantation, placental formation and subsequent 
delivery outcome”. 
 
2.2   Aims 
 
The aims of this project were: 
1. To establish a definition of CS scars, to assess their visibility during the course 
of pregnancy and to investigate the validity of TVS in evaluating these scars 
and the reproducibility of scar assessment methods.  
2. To investigate if possible association between CS scar and early pregnancy 
symptoms, implantation and CSP exists.  
3. To describe the effects of CS scars on subsequent placental development and 
migration. 
4. To follow the natural history of CS scars in pregnant women in terms of the 
longitudinal changes occurring to the scar dimensions and their clinical 
significance on uterine scar rupture. 
5. To explore the relation between ultrasound scar features and the actual scar 
appearance at repeat caesarean delivery.  
6. To study the added value of CS scar features and changes into a prediction 
model to predict the likelihood of successful trials of VBAC.  
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2.3   General methods 	  
We conducted a series of six prospective studies in order to achieve the aims above. 
These will be detailed in the subsequent chapters below. These studies were carried 
out at the early pregnancy assessment unit and the main ultrasound department of 
Queen Charlotte’s and Chelsea Hospital, London, and were approved by the local 
research and ethics committee (Appendix 1). Informed consent was obtained from 
all women after the nature of the ultrasound examination had been fully explained 
(Appendix 5). Outcome data were collected from the medical records of the patients 
attending the delivery suite and verified with the main maternal database of the 
hospital. Recruitment commenced in June 2010.  
 
Below we describe the general methods applied to conduct these studies, and these 
will be detailed further in the subsequent chapters accordingly.  
 
The research fellow (ON) and a senior sonographer (AS) with appropriate expertise 
in ultrasound scanning performed all ultrasound scan examinations. The 
examination was carried out transvaginally with the woman in the lithotomy position 
and with an empty bladder. The uterus was scrutinised in both sagittal and 
transverse planes for the presence of the old CS scar indentation, using an 
ultrasound system equipped with high-frequency transducers of 5-9 MHz (Voluson® 
E8 Expert, GE Healthcare Ultrasound, Milwaukee, Wisconsin, USA) covered with a 
disposable non-latex sheath.   
 
2.3.1   Ultrasound system settings 	  
The following settings were applied and followed in all the examinations performed: 
Frequency: Harmonics High 
2D gain: level 1 
Dynamic contrast: level 7 
Grey map: level 5 
Persistence (frame averaging): level 3 
Edge enhancement: level 3 
Speckle Reduction (SR): level 3 
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2.3.2   Image optimisation  	  
We set the depth in order to obtain a panoramic view of the lower segment 
including the cervical canal up to the external os where possible. After identifying 
the scar, we magnified the image so the scar occupied at least 50% of the image. 
This was to ensure consistent and accurate calibre measurements of the 
dimensions. The sector angle was set to the full range of 180°; thereby the axis of 
cervical canal could be demonstrated in relation to the lower segment.  
 
Applying the above, the endocervical canal was clearly visible as a hyper-echoic 
thin line within the cervical mantle; we took extra care to avoid exerting undue 
pressure on the cervix with the probe because this may falsely elongate the cervix. 
We identified the internal cervical ostium using one or more of the following four 
landmarks, depending on the body habitus of the patient (Images 2,3): 
 
1. At the level where there is slight narrowing in the lower uterine segment, 
between the uterine corpus and the cervix at the lower boundary of the urinary 
bladder 30. 
2. We used the endocervical mucosa to define the cervical canal. The level of 
the internal os appears as a V-shaped notch at the top of the canal, before 
reaching the thickened lower uterine segment	  72.  
3.  The uterovesical (UV) fold should be clearly visible as a hyper-echoic line 
between the bladder interface and the endocervical canal. 
4. The internal os is generally at the level of the uterine arteries. 
 
2.3.3   Caesarean section scar definition 
 
We used an agreed definition from our published report in Ultrasound Obstetrics 
Gynecology- March 2012; we adopted the following definition throughout the 
phases of these studies:  
 
“Hypo-echoic indentation at the anterior wall of the lower uterine segment, 
measurable in three dimensions and lies between the UV fold and the internal 
	   27	  
cervical os. In case of previous elective CS the indentation will appear halfway 
between the UV fold and the internal cervical os (Image 2), whilst in case of 
previous emergency CS the indentation will appear below or at the level of the os 
(Image 3)”.  
 
 
	  	  
Image 2: Ultrasound appearance of the CS scar at 7 weeks gestation between 
the UV fold and the internal cervical os 	  
 
 
 
Image 3: Ultrasound appearance of the CS scar at 12 weeks gestation at the 
level of the internal cervical os 
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2.3.4   Identifying CS scar by TVS 
 
Applying the methods described in sections 2.3.2 and 2.3.3 above, the CS scar 
should be well delineated in both sagittal and transverse planes. The width and 
depth calibres can both be obtained in the sagittal (Image 4). The scar indentation 
seen on the sagittal plane is then followed while slowly rotating the probe clockwise 
into the transverse plane. In this plane the scar will appear between the 
hyperechoic UV fold and the myometrial mantle; the calibre of the new shadow 
obtained represents the length of the scar (Image 5). 
Scar width!
Scar depth!
 
Image 4: Ultrasound appearance CS scar at 8 weeks gestation, width and 
depth measured in the sagittal plane 
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Scar length!
 
Image 5: Ultrasound appearance of CS at 9 weeks gestation, scar length 
measured in the transverse plane 
 
 
2.3.5   Identifying residual myometrial thickness (RMT) by TVS 
 
This is measured in the sagittal plane from the base of the hypoechoic segment of 
the scar to the hyperechoic line representing the UV fold (Image 6). In order to 
keep consistency in the measurement and to minimise the intra and inter-observer 
variability, measurement of the RMT must be carried out in the midline where the 
hyperechoic line of the endocervical canal is identified. The RMT is variable 
between women and can be from as thin as 0.5mm to more than 10mm. The 
reason for this is still unknown but it is possible to relate it to the healing process in 
each individual as well as to the gestational age of the pregnancy. 
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RMT!
 
 
Image 6: Ultrasound appearance of the (RMT) at 9 weeks gestation in the mid-
sagittal plane in line with the hyperechoic line of the endocervical canal  
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Chapter 3: Results 	  
This chapter is divided into six sections; each section describes study-specific 
methods, the data, the statistical analysis and the conclusions drawn.  
 
3.1   The visibility and measurement of caesarean section scars 
in pregnancy: intra and inter observer variability study. 
 
Objectives: 
To evaluate the visibility of CS scars by transvaginal sonography in pregnant 
women, to apply a standardised approach for measuring CS scars and to test its 
reproducibility throughout the course of pregnancy.  
 
Between June 2010 and July 2011, 389 non-selected consecutive women were 
enrolled in the study. We included women with singleton pregnancies who had 
undergone at least one previous low-transverse CS. Women with multiple gestations 
(n=19) were excluded from the study, as there would be increased pressure on the 
CS scar owing to the increased uterine volume. Those with a history of a classical 
CS (n=11) were also excluded from the study, as this involves very small numbers 
and an incision into a different part of the uterus. Thirteen women had a mid-
trimester spontaneous miscarriage, 17 withdrew from the study after subsequent 
scans and nine were lost to follow-up, thus the final study cohort consisted of 320 
women. At the initial scan visit, every patient was given a health questionnaire to 
record a brief obstetric history including the number of previous caesarean 
deliveries; these details were entered into the study database by administrative staff 
and neither of the examiners was aware of this information at the time of the 
examination. Two independent operators (ON, AS), who were blind to each other’s 
findings, performed the ultrasound examinations and applying the system 
specifications and image optimisation as explained in sections 2.3.1 and 2.3.2 
above. Delineation and measurements of the CS scar were carried out according to 
the methods described in sections 2.3.3-5 above.  
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The study was carried out in two stages. First, in order to reduce the time each 
patient was subjected to transvaginal scans; both operators only used real-time 
scanning to assess uterine version and scar visibility. Furthermore the scheduled 
appointment time for each examination (20, 30 and 15min for the first, second and 
third trimester, respectively) was not extended. At each examination episode the first 
operator assessed the LUS and noted whether the uterus was anteverted or 
retroverted and whether the scar was visible or non-visible. Images of the LUS were 
obtained and saved onto a hard drive. The examination was ended and the findings 
(regarding visibility and version of the uterus) were recorded in a dedicated 
database. The second operator took over the examination of the same patient, blind 
to the findings of the first operator, and repeated the steps described above. 
 
For the second part of the study, intra- and inter observer variability for measuring 
scar size was assessed off-line on the stored images independently obtained by 
each operator. Forty consecutive cases in each trimester were assigned for analysis. 
To obtain the images, the LUS was examined in the sagittal plane to identify the 
area likely to contain the CS scar. When the scar was deemed visible, each operator 
stored at least two images independently for off-line assessment. Using the stored 
images for all women, three measurements were taken in the sagittal plane: scar 
width, depth and RMT and scar length in the transverse plane, as illustrated in 
images 4-6 in the general methods chapter above. The above method was applied 
at each scan visit and measurements were taken at 12, 20 and 34 weeks gestation. 
 
For intraobserver variability, the first operator, using one of the acquired images i.e. 
the one that showed the scar most clearly, carried out the measurement for each 
scar dimension twice, with a short delay between the two measurements (about 10 
seconds). The first of the first operator’s measurements was selected for 
assessment of interobserver variability. For the latter, the second operator measured 
once the scar dimensions of the same image measured by the first operator. 	  
Statistical analysis: 
Systematic bias in scar measurements between observers was determined by 
calculating the mean of the differences between the observers and its standard error 
(SEM). A one-sample t-test with a significance level of 0.05 was applied to the 
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measurement differences, and the limits of agreement between both observers were 
calculated for each measurement as the mean ± (1.96 × SD). Fisher’s exact test was 
used to perform comparative analysis on scar visibility between anteverted and 
retroverted uteri. 
 
For intra and interobserver agreement, the intraclass correlation coefficient (ICC) 
based on a two-way random- effects ANOVA model was calculated. High absolute 
agreement corresponds to a high ICC (close to 1), with values > 0.75 indicative of a 
test with good agreement 73. 
 
The strength of absolute agreement between the two observers was measured 
according to Cohen’s kappa coefficient: 1.0- 0.81, excellent; 0.80- 0.61, good; 0.6- 
0.41, moderate; and < 0.41 fair agreement	   74. For the calculation of interobserver 
agreement, a cut-off of 2.4 mm, based on unpublished observations, was used for 
RMT. We have observed that the width, depth and length of CS scars vary across 
the trimesters of pregnancy, while RMT does not. Therefore a kappa coefficient 
could not be calculated for these variables. 
 
Results: 
A total of 320 women were included to assess scar visibility. At the 12-week scan the 
uterus was anteverted in 254 cases (79.4%), retroverted in 42 (13.1%) and axial in 
24 (7.5%). The latter type became anteverted in all cases on subsequent scans. The 
scar was visible to both operators in 284/320 cases (88.8%). When the scar was 
deemed to be visible at the 12-week scan, it continued to be visible in 100% of the 
cases at 20 weeks and in 272/284 cases (95.8%) at 34 weeks (Images 7, 8).  
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Image 7: Ultrasound appearance CS scar at 20 weeks gestation 
 
 
 
 
Image 8: Ultrasound appearance CS scar at 34 weeks gestation 
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There was 100% agreement on uterus version and scar visibility at the 12 and 20 
week scans. In the third trimester, the two operators disagreed in four cases (98.8% 
agreement, kappa coefficient 0.949). In these four cases it was decided to consider 
the scar as non-visible. In the anteverted group the CS scar was visible in 256/278 
cases (92.1%) while it was visible in 28/42 (66.7%) of the retroverted group (Image 
9, Table 2). Scars were significantly more visible in the anteverted group (Fisher’s 
exact test, P <0.0001). Amongst the 80/320 cases (25%) that had had more than 
one caesarean delivery, only one case had more than one visible scar. In this case 
measurements of the larger scar were taken. 
 
 
 
Image 9: Poorly visible CS scar at 10 weeks gestationin a retroverted uterus  
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Table 2: Visibility of CS scars in anteverted and retroverted uteri 
 
In the three subsets of 40 cases assigned for intra and interobserver variability 
assessment, the scar was visible in 37/40 cases in the first trimester, 39/40 in the 
second and 35/40 in the third (111 in total). Before the analyses, systematic bias 
between the two observers was assessed. In the first trimester, both scar width and 
length measurements were systematically higher for one observer than for the other 
(P = 0.034 and < 0.0001, respectively). This was not the case for scar depth and 
RMT (P = 0.26 and 0.22, respectively) (Figure 1). In the second trimester, there were 
no systematic biases between observers (P = 0.76, 0.95, 0.61 and 0.19 for scar 
width, depth and length and RMT, respectively) (Figure 2). 
N = 320 A/V Uterus R/V Uterus 
Visible scar 
284 (88.7%) 
256 28 
Non visible scar 
36 (11.3%) 
22 14 
Scar visibility (%) 92.1% 66.7% 
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Figure 1: Scatterplots for comparison between the two observers of CS scar 
measurements, width, depth, length and RMT at the 12-week scan (n=37). Line 
of equality is shown (O1= operator 1, O2= operator 2) 
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Figure 2: Scatterplots for comparison between two observers of CS scar 
measurements, width, depth, length and RMT at the 20-week scan (n=39). Line 
of equality is shown (O1= operator 1, O2= operator 2) 
 
In the third trimester, RMT measurements were systematically higher for one 
observer than the other (P = 0.0011). This was not the case for scar width, depth 
and length (P = 0.52, 0.12 and 0.098, respectively) (Figure 3). The means (SEM) of 
the differences between the two observers, with significant systematic biases 
indicated, and the limits of agreement are shown in table 3. For scar measurements, 
the limits of agreement were narrowest in the first trimester, and became wider in the 
second and third trimesters. For RMT, the limits of agreement were comparable 
across the three trimesters and narrower than those for the scar measurements. 
 
 
Figure 3: Scatterplots for comparison between two observers of CS scar 
measurements, width, depth, length and RMT at the 34-week scan (n=33). Line 
of equality is shown (O1= operator 1, O2= operator 2) 
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                     (Mean +/- SEM of differences (95% LoA)) 
Parameter Trimester 1 Trimester 2 Trimester 3 
Scar width (mm) -0.332 +/- 0.151*  
(-2.126 to 1.462) 
-0.099 +/- 0.327 
(-4.096 to 3.898) 
0.212 +/- 0.330 
(-3.610 to 4.034) 
Scar depth (mm) 0.317 +/- 0.277 
(-2.987 to 3.621) 
0.014 +/- 0.214 
(-2.602 to 2.630) 
-0.611 +/- 0.379 
(-5.007 to 3.785) 
Scar length (mm) 1.111 +/- 0.247 
(-1.830 to 4.052) 
0.151 +/- 0.299 
(-3.511 to 3.812) 
0.437 +/- 0.257 
(-2.547 to 3.422) 
RMT (mm) 0.215 +/- 0.173 
(-1.852 to 2.283) 
-0.237 +/- 0.177 
(-2.406 to 1.933) 
-0.555 +/- 0.156* 
(-2.364 to 1.255) 
 
*Significant systematic bias. RMT= residual myometrial thickness.  
Table 3: Mean (SEM) of differences between and 95% limits of 
agreement (LoA) for CS scar measurement by two observers across all 
three trimesters (n = 111) 
 
 
For intraobserver comparisons, we adopted the guideline of Jastrow (2006) that a 
difference of ≤ 1 mm in the measurement of scar width, depth, length and RMT 
obtained by several observers is acceptable	   24. For RMT, a difference ≤ 1 mm was 
achieved in 75.7% in the first trimester, 89.7% in the second trimester and 85.7% in 
the third trimester. For the other scar measurements, the difference was ≤ 1 mm in 
over 70% of cases when data from all trimesters were combined. Intraobserver 
agreement was generally good for RMT, with an ICC of > 0.8, and between 0.75 and 
0.95 for the other scar measurements (Table 4). 
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TRIMESTER 1 Percentage of 
differences 
<=1mm 
Mean (SD) of 
differences (mm) 
ICC (95% CI) 
Scar width 70.3 0.770 (0.821) 0.753 [0.570 0.864] 
Scar depth 73.0 2.087 (7.931) 0.956 [0.916 0.977] 
Scar length 59.5 1.106 (1.128) 0.905 [0.822 0.950] 
RMT 75.7 0.640 (0.724) 0.874 [0.766 0.933] 
Measurements 
combined 
69.6 0.829 (0.884) 0.965 [0.952 0.974] 
TRIMESTER 2 Proportion (%) of 
differences 
<=1mm 
Mean (SD) of 
differences (mm) 
ICC (95% CI) 
Scar width 71.8 0.723 (0.781) 0.905 [0.826 0.949] 
Scar depth 71.8 0.833 (0.871) 0.867 [0.762 0.928] 
Scar length 92.3 0.470 (0.529) 0.945 [0.898 0.971] 
RMT 89.7 0.475 (0.390) 0.815 [0.669 0.900] 
Measurements 
combined 
81.4 0.625 (0.683) 0.950 [0.931 0.963] 
TRIMESTER 3 Proportion (%) of 
differences 
<=1mm 
Mean (SD) of 
differences (mm) 
ICC (95% CI) 
Scar width 68.6 0.646 (0.722) 0.951 [0.904 0.975] 
Scar depth 82.9 0.637 (0.756) 0.766 [0.584 0.875] 
Scar length 65.7 0.744 (0.696) 0.876 [0.757 0.937] 
RMT 85.7 0.403 (0.468) 0.890 [0.677 0.954] 
Measurements 
combined 
75.7 0.608 (0.675) 0.957 [0.938 0.969] 
Trimesters 
combined 
Proportion (%) of 
differences 
<=1mm 
Mean (SD) of 
differences (mm) 
ICC (95% CI) 
Scar width 70.3 0.714 (0.771) 0.938 [0.912 0.957] 
Scar depth 75.7 0.760 (0.802) 0.940 [0.913 0.958] 
Scar length 73.0 0.768 (0.856) 0.938 [0.911 0.957] 
RMT 83.8 0.508 (0.549) 0.879 [0.805 0.922] 
Measurements 
combined 
75.7 0.688 (0.759) 0.960 [0.952 0.967] 
SD = standard deviation, CI = confidence interval 
 
Measurements combined represent all measured values for scar width, depth and 
length and RMT per trimester as well as for all trimesters combined. 
 
Table 4: Intraobserver agreement for scar width, scar depth, scar length and 
residual myometrial thickness (RMT) obtained by one observer, with a 10 
seconds interval between measurements (n=111) 
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Regarding interobserver agreement, 77.5% of the differences in RMT measurement 
between two observers across all trimesters were within the acceptable range of ≤ 1 
mm. However, equivalent values for scar width, depth and length were 52.3, 56.8 
and 47.7%, respectively. Using an RMT cut-off of 2.4 mm, the kappa coefficient was 
0.266 (95% CI –0.123 to 0.655) in the first trimester, 0.513 (95% CI, 0.187–0.840) in 
the second trimester and 0.719 (95% CI, 0.491–0.947) in the third trimester. 
Because of changing values of other scar measurements across all trimesters, cut-
off values for these readings could not be established. Overall, ICC was > 0.8 for 
scar width, depth and length measurement across all trimesters, and was 0.71 for 
RMT (Table 5). 
TRIMESTER 1 Proportion (%) of 
differences <=1mm 
ICC (95% CI) Kappa coefficient 
(95% CI)* 
Scar width 64.9 0.793 [0.623 0.890]  
Scar depth 37.8 0.887 [0.792 0.940]  
Scar length 29.7 0.860 [0.567 0.943]  
RMT 78.4 0.785 [0.622 0.883] 0.266 [-0.123 0.655] 
 
Measurements 
combined 
 0.945 [0.922 0.960]  
TRIMESTER 2 Proportion (%) of 
differences <=1mm 
ICC (95% CI) Kappa coefficient 
(95% CI) 
Scar width 51.3 0.678 [0.462 0.817]  
Scar depth 71.8 0.826 [0.693 0.905]  
Scar length 53.8 0.628 [0.393 0.786]  
RMT 74.4 0.550 [0.291 0.734] 0.513 [0.187 0.840]  
Measurements 
combined 
 0.844 [0.792 0.884]  
TRIMESTER 3 Proportion (%) of 
differences <=1mm 
ICC (95% CI) Kappa coefficient 
(95% CI) 
Scar width 40.0 0.834 [0.697 0.913]  
Scar depth 60.0 0.396 [0.088 0.638]  
Scar length 60.0 0.750 [0.559 0.865]  
RMT 80.0 0.705 [0.391 0.856] 0.719 [0.491 0.947] 
 
Measurements 
combined 
 0.842 [0.786 0.884]  
Trimesters 
combined 
Proportion (%) of 
differences <=1mm 
ICC (95% CI) Kappa coefficient 
(95% CI) 
Scar width 52.3 0.842 [0.778 0.889]  
Scar depth 56.8 0.834 [0.767 0.883]  
Scar length 47.7 0.850 [0.773 0.899]  
RMT 77.5 0.711 [0.605 0.792] 0.542 [0.370 0.713] 
 
Measurements 
combined 
 0.896 [0.876 0.913]  
 
Measurements combined represent all measured values combined. *RMT only. 
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Table 5: Interobserver agreement in measurement of scar width, scar depth, 
scar length and RMT by intraclass correlation coefficient and kappa coefficient 
across three trimesters (n = 111) 
 
Discussion:  
We have shown that CS scars can be visualized with a high level of agreement 
between observers in all three trimesters of pregnancy, and that failure to identify the 
scar is most often associated with retroversion of the uterus. Furthermore, if the scar 
is visible in the first trimester it remains visible throughout the rest of the pregnancy.  
 
Our data suggest that measurements of CS scar dimensions are reasonably 
reproducible, with good interobserver agreement in the first trimester and moderate 
agreement in the second and third trimesters. Agreement on the measurement of 
RMT was also within acceptable limits, with an ICC of 0.711 for all trimesters 
combined. 
 
Our study showed a scar detection rate of 89%. This is high in comparison with other 
studies reporting on the visibility of CS scars with ultrasound, where CS scar visibility 
has ranged between 7 and 69% 60. This is possibly owing to the use of higher 
frequency TVS in our study. In fact, Martins (2009) reported, in a study of 30 
pregnant women scanned between 36 and 39 weeks gestation, that TVS provides 
greater reliability for LUS measurement than TAS	  25. Another important reason could 
be differences in the study populations. Most studies that have reported on the 
prevalence of visible scars have been carried out in non-pregnant patients 4	   62	   75, 
whereas our study was performed on pregnant women where the presence of 
amniotic fluid acts as a negative contrast agent, resulting in improved scar visibility 
and clearer margins. 
 
The scar was almost always visible when the uterus was anteverted (92.1% 
visibility), but the number of visible scars decreased when the uterus was retroverted 
(66.7% visibility). This is in contrast to the findings of Ofili-Yebovi (2008) where large 
‘deficient’ scars were found to be associated with retroverted uteri	  4. We suggest that 
this discrepancy relates to the tension put on the scar by the position of the uterus; 
when retroverted, the internal surface of the lower segment is brought together, and 
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a smaller, better-healed scar may result, hence limiting visibility. In addition, the 
study by Ofili-Yebovi and colleagues was carried out in non-pregnant women, which 
might explain the differences in findings (Image 9) above. 
 
We tested the reproducibility of the use of ultrasound to measure CS scars in 
pregnancy using both ICC, which measures variation between observers and 
subjects 25, and 95% limits of agreement. The results of our intra and interobserver 
variability analysis for RMT measurement, calculated using the kappa coefficient are 
in agreement with those of Jastrow (2006)	   24. However, Jastrow adopted an LUS 
thickness of 3.5 mm as a cut-off to indicate a risk of uterine rupture, while we used a 
cut- off of 2.4 mm. The 3.5mm measurement was initially proposed by Rozenberg 
(1996) in a study that aimed to evaluate the usefulness of sonographic measurement 
of the LUS for the prediction of intrapartum uterine rupture	  62. This study was carried 
out at 38 weeks’ gestation, at which time it is known that descent of the presenting 
part starts, leading to compression of the lower uterine segment	  75. This may limit the 
utility of ultrasound for the assessment of the LUS at this gestational age.  
 
Rozenberg also measured the LUS by a single operator using TAS. However, 
Martins conducted a study to assess the reliability of measuring the muscular layer 
of the LUS (partial thickness) by TVS versus the entire LUS (full thickness) by TAS 
in pregnant women between 36 and 39 weeks’ gestation	  25. The conclusion was that 
measuring the partial thickness by a transvaginal approach is more reliable. 
Moreover, in a systematic review by Jastrow and colleagues on the diagnostic 
accuracy of measurement of the LUS by ultrasound to predict uterine scar defects, 
they found that the optimal cut-off values for partial thickness ranged between 1.4 
and 2.0mm. However, because of the heterogeneity of the studies, they concluded 
that no ideal cut-off values could be recommended	  23. We chose 2.4 mm as a cut-off 
value for assessing interobserver variability. We found good agreement between the 
two observers regarding CS scar measurements during the first trimester, and 
moderate agreement for the second and third trimesters. However, there was a 
degree of systematic bias, with some scar measurements between the two 
observers, emphasising the need for a standardised approach. 
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This study was performed within the routine clinical setting, i.e. at the time of the 
nuchal translucency measurement in the first trimester and fetal biometry and 
anomaly screening in the second trimester. The allocated time slot was not 
increased to accommodate the additional TVS scans. This pressure of time did not 
permit both operators to obtain scar measurements in real-time for all 320 cases – a 
limitation of the study. However, demonstrating that CS scars can be reliably 
visualized and quantified is an important initial step in determining whether 
ultrasound-based assessment of CS scars may have a role in the prediction of CS 
scar integrity in labour and other related pathologies. 
 
3.2   Does the presence of a caesarean section scar affect 
implantation site and early pregnancy outcome in women 
attending an early pregnancy assessment unit?  
 
Objectives: 
To compare the location and distance to the internal cervical os of the implantation 
site for intra-uterine gestational sacs, current pregnancy symptoms and the 
pregnancy outcome at 12 weeks gestation between women with and without a 
previous caesarean section. 
 
During a 15-month study period (June 2010 to September 2011), consecutive non-
selected cases were recruited. Any pregnant woman attending for an early 
pregnancy scan was given an information sheet describing the nature and the aim of 
the study and a health questionnaire concerning her past obstetric history. 
Generally, there are three criteria for assessing women in our early pregnancy 
assessment unit (EPAU): vaginal bleeding and/or pain, for patient anxiety or for 
reassurance in the event of previous ectopic pregnancy or spontaneous miscarriage. 
From this cohort, we recruited patients who fulfilled the following eligibility criteria: 
• Singleton intra uterine pregnancy 
• Gestational age at 6-11 weeks  
• No previous history of open uterine surgery or classical CS, except lower     
uterine segment CS. 
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Patients with cervical or interstitial ectopic, pregnancy of unknown location (PUL)	  76, 
complete or incomplete spontaneous miscarriage were excluded from the study 77. 
 
Patients completing the health questionnaire were requested to note their previous 
obstetric history, the number of previous CS and other demographic data i.e. age, 
ethnicity and body mass index (BMI) as well as current pregnancy symptoms. 
Vaginal bleeding was recorded using a modified pictoral blood loss assessment 
chart  (PBAC) 78,	   ranging from 1 in cases of brown discharge to 5 in cases of 
bleeding with clots and flooding	  (Figure 4).  
 
 
 
Figure 4: Modified pictoral blood loss assessment (PBAC) chart 
 
The clinical research fellow (ON) performed all the ultrasound examinations and 
applying the system specifications and image optimisation as explained in sections 
2.3.1 and 2.3.2 above. Delineation and measurements of the CS scar were carried 
out according to the methods described in sections 2.3.3 - 2.3.5 above.  
 
When an intra uterine pregnancy was identified, the following ultrasound findings 
were documented: 
 
1. Implantation site in relation to the endometrial cavity. For the purposes of this 
study and to obtain consistent findings, it was decided to have only 5 subgroups 
of gestational site implantation in relation to the endometrial cavity (Figure 5): 
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• Anterior 
• Posterior  
• Fundal  
• Low-lying anterior  
• Low-lying posterior  
 
 
	  
Figure 5: Gestational sac implantation sites in relation to the 
endometrial cavity (A: fundal, B: anterior, C: posterior, D: low-lying 
anterior, E: low-lying posterior) 	  
We adopted the definition of implantation site from Abdallah (2012) 79. The 
implantation site is visualized in the sagittal plane as a hyperechoic ring that 
occupies one side of the implanted gestational sac and protrudes into the 
endometrial lumen (Image 10). It represents the maternal decidual reaction and the 
beginning of maternal-fetal circulation. This area is also believed to be responsible 
for future placental formation and development 39.  
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Image 10: Implantation site in non-scarred uterus at 5 weeks gestation 
posterior to the endometrial cavity (solid arrow), and implantation 
site- internal cervical os (dotted arrow) 
 
2. Distance between the implantation site and the internal cervical os. This was 
taken from the lower end of the hyperechoic trophoblast ring of the gestational sac to 
the internal cervical os in the sagittal plane, as illustrated in Image 10 above. 
Methods of identifying the internal cervical os were applied as illustrated in section 
2.3.2 in the general methods chapter above.  
 
3. Subjective assessment of the relationship between the implantation site and CS 
scar. Four classifications were used (Figure 6): 
• Away from the scar 
• Close to the scar 
• Crossing the scar  
• Inside the scar, known as CSP 
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Figure 6: Classification of gestational sac implantation in relation to 
the caesarean scar by subjective impression (A: away from scar, B: 
close to scar, C: crossing the scar, D: inside the scar causing 
caesarean scar pregnancy) 
 
 
Methods of diagnosing CSP were adopted from Ash (2006) 41. In order to 
discriminate between implantation close to or crossing the scar and a spontaneous 
miscarriage passing through the lower part of the uterus we ensured there was an 
embryonic heartbeat when appropriate, a negative sliding sign as well as the 
presence of trophoblast vascularity.  
 
The final outcome of the study was the viability of the pregnancy at 12 weeks 
gestation. All data were entered regularly into a designated research database and 
checked for missing, out of range and inconsistent values.  
  
Statistical analysis: 
Baseline characteristics between women with and without previous caesarean in 
demographic variables are presented using descriptive statistics. Differences 
between the patients with and without caesarean history are investigated using 
statistical significance testing for the following variables: presenting symptoms (chi-
square test), implantation sites (chi-square test), distance from the implantation site 
to the internal cervical os (t-test), PBAC scores (logistic regression) and pregnancy 
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outcome (multiple logistic regression). However, we always report effect sizes with 
95% confidence intervals (CI) as the most important result. For the association of 
PBAC scores with caesarean history, the c-statistic was used as a measure of effect 
size. This estimates the probability that a woman with a previous caesarean has a 
higher score than a woman without a previous CS. The multiple logistic regression 
analysis to study the influence of CS on pregnancy outcome includes the following 
covariates to correct for confounding: implantation site, age, parity and presenting 
complaint. In addition we explore whether the effect of caesarean section is modified 
by the covariates through interaction terms. There were no missing values and no 
observations were lost to follow-up. 
 
Results: 
The study population comprised 380 women, of which 170 cases had at least one 
previous caesarean delivery and 210 cases had no previous uterine surgery. Overall 
306/380 cases (81%) were symptomatic (bleeding and/or pain) and 74/380 (19%) 
had no symptoms. Women with a previous caesarean delivery tended to be slightly 
older (median 34 versus 33 years old), to have a slightly higher gravidity (median 4 
versus 3) and a higher BMI (median 27 versus 25 kg/m2) than women without 
previous caesarean delivery. Moreover, there are more of white ethnic group and 
smokers among women with a history of caesarean delivery (64 versus 56% and 14 
versus 7%, respectively). The parity and number of spontaneous miscarriage were 
comparable across the two groups (Table 6). 
 
 
 
 
 
 
 
 
 
 
 
 
	   50	  
Variable Statistic Caesarean in the past 
No (n=210) Yes (n=170) 
Age (years) Median 
(min, Q1, Q3, max) 
33 
(18, 28, 37, 45) 
34 
(22, 29, 39, 46) 
Gravity  Median 
(min, Q1, Q3, max) 
3 
(2, 2, 4, 7) 
4 
(2, 3, 4, 8) 
Parity  Median 
(min, Q1, Q3, max) 
2 
(0, 1, 3, 5) 
2 
(1, 1, 3, 5) 
Previous miscarriage  Median 
(min, Q1, Q3, max) 
0 
(0, 0, 1, 5) 
0 
(0, 0, 1, 3) 
BMI (kg/m2) Median 
(min, Q1, Q3, max) 
25 
(18, 23, 28, 37) 
27 
(20, 24, 30, 40) 
Smoking=Non-smoker N (%) 164 (78%) 118 (69%) 
Smoking=Ex-smoker N (%) 32 (15%) 28 (16%) 
Smoking=Current  N (%) 14 (7%) 24 (14%) 
Ethnicity=White N (%) 117 (56%) 109 (64%) 
Ethnicity=Black N (%) 46 (22%) 33 (19%) 
Ethnicity=Asian N (%) 35 (17%) 20 (12%) 
Ethnicity=Other N (%) 12 (6%)  8 (5%) 
 
Table 6: Descriptive statistics: demographic characteristics of 
patients with and without prior history of caesarean delivery 
(min=minimum, Q1=first quartile, Q3=third quartile, max=maximum). 
Significance between groups was not assessed 
 
There was a significant association between the presenting criteria and the presence 
of a caesarean scar (Table 7, P= 0.0009). In the non-CS group 115/210 cases (55%) 
presented with vaginal bleeding compared with 124/170 cases (73%) in the CS 
group (difference -18%, 95% CI -27 to -8%). Women without a previous CS 
presented more often with lower abdominal cramps or for a reassurance scan than 
women who had a previous CS (22 versus 12%, difference 11%, 95% CI 3 to 18%, 
and 23 versus 15%, difference 8%, 95% CI -0 to +15%, respectively).   
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 Caesarean in past Number of caesareans Total 
Presenting 
Criteria No 
N (%) 
Yes 
N (%) 
Colum 
percent 
difference  
(95% CI) 
1 
N (%) 
>1 
N (%) N 
Bleeding 115 (55) 124 (73)  -18 (-27, -8) 98 (78) 26 (59) 239 
Pain 47 (22) 20 (12)  11 (3, 18) 10 (8) 10 (23) 67 
Reassurance 48 (23) 26 (15)  8 (-0, 15) 18 (14) 8 (18) 74 
Total 210 170   126 44 380 
 
Table 7: Differences in the frequency of the early pregnancy unit 
presenting criteria in patients with and without prior history of 
caesarean delivery (P =0.0009) 
 
For vaginal bleeding the median PBAC score was 3/5 in the CS and 2/5 in the non 
CS group. Women who have had a previous CS tend to have higher PBAC scores 
than women without a previous CS (c-statistic = 0.69, 95% CI 0.63 to 0.74).  
 
The frequency of different gestational sac implantation sites between the two groups 
is illustrated in table 8. There is a significant difference in the site of implantation 
between the two groups (P <0.0001). In the CS group posterior implantation was 
observed most frequently (54 versus 31%, difference -23%, 95% CI -32 to -13%), 
while in the non-CS group fundal implantation was observed most frequently (42 
versus 23%, difference 19%, 95% CI 10 to 28%). Low-lying anterior and posterior 
implantations occurred in low but similar frequencies in both non-CS and CS groups 
(1.9 versus 2.3%, difference -0.5%, 95% CI -4.2 to 2.8%, and 2.4 versus 1.2%, 
difference 1.2%, 95% CI -2.1 to 4.4%, respectively).  
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 Caesarean in past Number of caesareans Total 
Implantation Site 
No 
N (%) 
Yes 
N (%) 
Column 
percent 
difference 
(95% CI) 
1 
N (%) 
>1 
N (%) N 
Anterior 47 (22) 33 (19) 3 (-5, 11) 22  (17) 11 (25) 80 
Fundal 89 (42) 39 (23) 19 (10, 28) 31 (25) 8 (18) 128 
Low-lying anterior 4 (1.9) 4 (2.3) -0.5 (-4.2, 2.8) 3 (2.3) 1 (2.2) 8 
Low-lying posterior 5 (2.4) 2 (1.2) 1.2 (-2.1, 4.4) 1 (0.8) 1 (2.2) 7 
Posterior 65 (31) 91 (54) -23 (-32, -13) 68 (54) 23 (52) 156 
Scar pregnancy 0 1 (0.6)  (N/A) 1 (0.8) 0 1 
Total 210 170  126 44 380 
 
Table 8: Differences in the distribution of different implantation sites 
within the uterine cavity between the caesarean and non-caesarean 
groups (P <0.0001) 
 
For the distance between the implantation site and the internal cervical os, there was 
a significant association between the mean distance and the presence of a CS scar 
(P <0.0001). The mean distance among women with and without previous CS was 
26.6mm and 35.3mm respectively, (Figure 7, difference 8.7 mm, 95% CI 6.7 to 10.7 
mm). The number of previous CS did not have an effect on the implantation 
distance. 
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Figure 7: Differences in the distance between the implantation site 
and the internal cervical os among the caesarean and non-caesarean 
groups (P < 0.0001). Diamonds represent group means, boxes rep- 
resent the interquartile ranges (IQR), horizontal bars within the boxes 
represent the medians, whiskers represent the lowest/ highest data 
points within 1.5 IQR of the lower/upper quartiles and dots represent 
outliers 
 
The pregnancy outcome at 12 weeks in both groups is illustrated in table 9. Among 
women with a previous CS, 29% miscarried, compared to 24% of women without a 
previous CS. In a multivariable analysis, taking implantation site, presenting 
complaint, age and parity into account, previous CS did not have an independent 
effect on the outcome at 12 weeks (OR= 1.1, 95% CI 0.6 to 1.9, P =0.74).  
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 Caesarean in 
past 
Number of 
caesareans Total 
Outcome at 12 weeks No 
N (%) 
Yes 
N (%) 
1 
N (%) 
>1 
N (%) N 
Spontaneous miscarriage 51 (24) 49 (29) 35 (28) 14 (32) 100 
Viable 159 (76) 120 
(71) 
90 (72) 30 (68) 279 
Total 210 169 125 44 379* 
 
*One case diagnosed with CSP and was managed by suction evacuation 
and therefore excluded from the analysis.  
 
Table 9: Pregnancy outcome at 12 weeks gestation among the 
caesarean and non-caesarean groups 
 
In the CS group (n= 170), subjective impression of the location of the implantation 
showed 141 cases away from the scar, 20 close to the scar, eight cases crossed the 
scar and one case implanted into the scar (CSP) that was diagnosed at 7 weeks 
gestation and managed by suction and evacuation under direct ultrasound guidance. 
The subjective impression of the examiner was supported by the measurements of 
implantation to CS scar distance. The mean distance for the cases implanted away 
from the scar was 29.6 mm, while it was 14.7 and 3.8 mm for the ones implanted 
close and crossing the scar, respectively. There was no overlap in the distances 
between these groups.  
 
Among the cases where implantation was away from the scar, 22% had a 
spontaneous miscarriage, compared with 55 and 88% among women with 
implantation close to and crossing the scar respectively. The probability of a 
spontaneous miscarriage increased as the implantation site approached the scar 
(Table 10).  
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Outcome at 12 weeks  
Viable 
N (%) 
Miscarriage 
N (%) 
 Total 
Im
pl
an
ta
tio
n 
si
te
 b
y 
su
bj
ec
tiv
e 
im
pr
es
si
on
 
Away from 
scar 
110 (78) 31 (22)  141 
Close to 
scar 
9 (45) 11 (55)  20 
Crossing 
the scar 
1 (13) 7 (88)  8 
 
Total 120 49 1* 170 
 
* One case of caesarean scar pregnancy 
 
Table 10: Implantation site by subjective impression and outcome at 
12 weeks 
 
Multivariate analysis taking presenting complaint, age and parity into account 
suggests that closeness to the scar influences the risk of spontaneous miscarriage 
(P=0.0003, OR away versus crossing=0.024, 95% CI 0.02 to 0.263, OR close 
versus crossing=0.114, 95% CI 0.009 to 1.395). Among the eight cases that 
implanted across the scar, seven cases ended with spontaneous miscarriage and 
one case survived to term. The surviving embryo was followed up closely 
throughout the course of the pregnancy. At the 12-week scan a single viable 
intrauterine pregnancy was identified and a low-lying placenta was confirmed, 
which subsequently evolved into a grade II placenta praevia (Image 11-13). An 
elective repeat CS delivery at 39 weeks gestation was carried out for this case that 
was straightforward other than an estimated 1.6-litre blood loss.  
 
The relationship of the number of previous caesarean deliveries with presenting 
complaint, severity of vaginal bleeding, implantation site, internal cervical os 
distance and spontaneous miscarriage before twelve weeks was investigated. 
None of the variables were strongly influenced by the number of previous 
caesarean deliveries.  
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       Image 11: Gestational sac implanted across the scar at 7 weeks gestation 
 
 
Image 12: Follow up of image 12 at 20 weeks gestation 
 
 
 
Image 13: Follow up of image 12 at 34 weeks gestation 
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Discussion: 
We have shown that women attending an early pregnancy unit with a caesarean 
scar on the uterus experienced more bleeding than women without previous uterine 
surgery. This is of interest in view of recent ultrasound studies showing that large CS 
scars are often associated with an absence of re-epithelialization and abnormal 
vascularization 80.  
 
We also found differences in the site of gestational sac implantation.  In the CS 
group they were mainly posterior whilst they were fundal in non-scarred uteri. Our 
data showed that anterior implantation occurs more often in women with more than 
one caesarean than in women with only one caesarean (25% versus 17%, 
respectively). These findings are similar to a previous case control study we 
conducted to investigate the effect of CS scar on placental location and subsequent 
migration. This study consisted of 2594 consecutive asymptomatic women who were 
examined at the time of their routine 11 to 14 week scan. We found significantly 
more posterior and fewer fundal placentas in the caesarean group than the control 
group 40. However we must exercise some caution when comparing results between 
these two studies with different study populations.  
 
Our study also suggests that for women attending an early pregnancy unit, a scarred 
uterus may be associated with a higher spontaneous miscarriage rate than women 
with no history of CS, although the difference was not statistically significant. Our 
data show a positive association between the number of previous caesarean 
deliveries and early pregnancy loss. In other studies examining this issue, Hemminki 
did not allow for calculations of risk ratios in relation to the outcome of pregnancies 
after CS 35. However, in this study it was explained that if the proportion of women 
who had had a spontaneous miscarriage is recalculated using the denominator as a 
figure corrected by the mean number of pregnancies, an increased risk of 
spontaneous miscarriage is found (risk ratio 1.2). Douglas (1963) also reported an 
increased risk of spontaneous miscarriage with a CS 81.  
 
We acknowledge that a limitation of our study is the lack of a reference technique to 
verify the location of implantation. Although we have made every effort to ensure that 
pregnancies apparently implanting lower in the uterus or close to the scar are not 
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simply pregnancies in the process of spontaneous miscarriage, it is possible that in 
some cases this may have been the case. A further potential criticism is that we did 
not examine scar dimensions and morphology, as our focus was on the location of 
the implantation site in relation to the scar, rather than the scar itself. Future studies 
looking at the impact of these factors on implantation would certainly be of interest. 
 
We used subjective impression by the operator to describe the relationship between 
the implantation site and the previous CS scar. The subjective impression of the 
examiner was supported by the measurements of implantation to CS scar distance. 
The mean distance for the cases implanted away from the scar was 29.6 mm, while 
it was 14.7 and 3.8 mm for the ones implanted close and crossing the scar, 
respectively. There was no overlap in the distances between these groups. Our data 
showed that 22% of cases that implanted away from the scar miscarried before 12 
weeks of gestation, compared with 55% for cases close to the scar and 88% when 
implantation was across the scar. This is potentially an important finding, although 
we must be cautious in view of the relatively small sample size. It is important to note 
that implantation sites that crossed the CS scar were not associated with heavy 
bleeding, although they were associated with spontaneous miscarriage. 
Furthermore, in the case that did not miscarry, the pregnancy survived to term and 
led to a live birth without catastrophic morbidity for the mother. It seems likely that 
there is a spectrum whereby the pregnancy may implant over the scar, with the 
degree of likely morbidity and the diagnosis of true CSP related to how far into the 
scar the pregnancy implants. This spectrum means that great care must be taken in 
order not to over-diagnose CSP, as although minor scar involvement may lead to a 
level of pathological placentation, this may not be sufficient to justify termination of a 
pregnancy. Currently, the diagnostic performance of ultrasound to diagnose CSP is 
not known. 
 
Several studies have described CS scars using ultrasound without establishing a 
relationship between the appearances of the scar and likelihood of CSP 42.  
 
Our results add further evidence to the hypothesis that the presence of a caesarean 
scar on the uterus impacts on the implantation site of a future pregnancy. They 
suggest an indirect effect of CS scar on spontaneous miscarriage as it increases the 
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risk of bleeding. We cannot say on the basis of our data whether the presence of a 
CS scar has any impact on the risk of spontaneous miscarriage in general, although 
this is a possibility that should be explored further. Furthermore, our analyses 
suggest it is not the mere presence of the scar that affects the risk of spontaneous 
miscarriage, but the closeness of the implantation site to the scar.  Our observations 
that the implantation may approach and cross the CS scar without implanting into 
the scar are novel and have implications for the diagnosis of CSP. Whilst criteria for 
diagnosis of CSP have been proposed the test performance of these have never 
been tested. Our findings suggest that there may be potential to over-diagnose CSP, 
a scenario likely to end in termination of the pregnancy. Similarly although 
implantation into the scar led to a delivery complicated by serious bleeding, this may 
have been an outcome accepted by the mother had we been able to accurately 
quantify the risks based on the ultrasound findings. There is clearly a need for further 
studies that examine this. Given the relatively high CS rate worldwide more women 
are embarking on pregnancies with a scar on their uterus, CS scar related morbidity 
will become of increasingly important. Our data add further to evidence that a CS 
scar impacts on future implantation and shows that there is likely to be a spectrum of 
pregnancy outcomes that mirrors the relationship of a CS scar and the implantation 
site of the index pregnancy.  
3.3   Does the presence of a caesarean section scar influence 
the site of placental implantation and subsequent migration in 
future pregnancies:  A prospective case-control study 
	  
Objectives: 
To describe placental location in the first trimester of pregnancy and subsequent 
placental migration in women with and without a history of previous caesarean 
delivery. 
 
During a 14-month period (June 2010 to July 2011), 2738 consecutive non-selected 
cases had a routine dating scan in the first trimester at Queen Charlotte’s Hospital, 
and comprised the study cohort. Women with a multiple gestation (n = 81) or with a 
history of previous uterine surgery other than a CS (n = 63) were excluded. The final 
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study group thus consisted of 2594 women, of whom 738 had a history of caesarean 
delivery and 1856 had no history of caesarean delivery (Figure 8).  
 
Obstetric history including number of previous caesarean deliveries and other 
demographic data (including age, ethnicity and body mass index (BMI)) were 
documented. All ultrasound scans were performed at 11 – 14 weeks’ gestation at the 
time of the routine first-trimester screening examination. The placenta was located 
transabdominally with a normally filled bladder. For the purposes of this study and to 
obtain consistent findings between all operators, it was decided to have only five 
placental-location subgroups. 
 
Figure 8: Flow-chart illustrating patient selection and recruitment 
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If the placenta was thought to be ‘right anterior’, it was classified as ‘anterior’, and 
similarly ‘left posterior’ was considered to be ‘posterior’. Therefore, placental 
locations were recorded using the following five subgroups: anterior, posterior, 
fundal, low- lying anterior and low-lying posterior (Figure 9). 
 
 
 
!" #"
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%"&"
 
Figure 9: Placental location classified by ultrasonography. A, anterior; B, 
posterior; C, low-lying anterior; D, low-lying posterior; E, fundal 
 
A low-lying placenta was defined in accordance with our hospital protocol as being 
one in which the placental edge was located within 2 cm of the internal os. Patients 
diagnosed with low-lying subtypes at the 11–14 week scan underwent further 
ultrasound examinations at 20 and 34 weeks’ gestation as part of routine clinical 
practice and the study protocol. 
 
Of the main cohort, 49 non-selected consecutive cases were assigned to test 
interobserver agreement for the classification of placental location. At the 12-week 
scan both operators used real-time scanning to assess placental location. At each 
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examination episode, the first operator assessed placental location in both sagittal 
and transverse planes. The examination was ended and the findings were recorded 
in a dedicated database. The second operator took over the examination of the 
same patient, blind to the findings of the first operator, and repeated the steps 
described above. These patients were followed up at the 20 week scan, in which one 
of the two operators assessed placental location without having access to the early 
scan findings, and recorded the findings on a separate database. 
 
Statistical analysis: 
The chi-square test was used to perform comparative analysis on placental location 
between the CS and control groups and to assess placental migration of the low- 
lying subtypes. One-way ANOVA was used to test the influence of continuous 
variables on placental location and migration. When P was < 0.05, post-hoc tests 
were performed to verify which placental locations had a significant difference in the 
continuous variable of focus (two-sample t-test). To study the influence of categorical 
and ordinal variables on placental location and migration, the chi-square test and 
Fisher’s exact test were used where appropriate. For parity and spontaneous 
miscarriage/termination, those with five or above were included in one group. 
 
Results: 
Overall analysis of the demographic variables of both groups showed that age had a 
significant influence on placental site in the control group (Table 11). In the control 
group, the mean age of the patients was 31.3 (range, 16 – 54) years and the mean 
BMI was 31 (range, 24 – 38) kg/m2. Women with a fundal placenta were found to be 
significantly younger (mean age, 30.7 years) than women with a low-lying placenta 
(mean age, 34.7 years; P = 0.019). None of the other continuous variables (height, 
weight and BMI) was found to be significantly associated with any specific placental 
location. In the CS group, the mean age was 33.7 (range, 19–49) years and the 
mean BMI was 34.5 (range, 27 – 42) kg/m2. An overall comparison of the mean of 
the other continuous variables did not show a statistically significant difference 
across the five placental locations. 
 
Using the chi-square test, we assessed the association of categorical and ordinal 
variables (ethnicity, parity and spontaneous miscarriage) as well as the number of 
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previous caesarean deliveries with the five placental locations recorded in both 
groups. None of the categorical variables was significantly associated with a 
particular placental location in either group. The number of previous caesarean 
deliveries did not differ between placental locations (P = 0.925). 
 
The frequency of different placental locations between the two groups is illustrated in 
table 12. In the CS group, posterior and anterior placental implantation occurred with 
similar frequency (47.2% and 45.3%, respectively).  
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Parameter 
Control group 
Mean (range) or n 
(%) 
P 
CS group 
Mean (range) or  
n (%) 
P 
Age (years) 31.3 (16-54) 0.019* 33.7 (19-49) 0.577* 
BMI (kg/m2) 31 (24-38) 0.545* 34.5 (27- 42) 0.516* 
Height (m) 1.72 (1.54-1.9) 0.196* 1.67 (1.48-1.86) 0.800* 
Weight (kg) 97.5 (57- 138) 0.451* 103.5 (61- 146) 0.436* 
Ethnicity  0.641°  0.988° 
White 1142 (61.5)  365 (49.5)  
Black 243 (13.1)  155 (21.0)  
Asian 239 (12.9)  93 (12.6)  
Chinese 26 (1.4)  7 (0.9)  
Other 206 (11.1)  118 (16.0)  
Parity  0.700°  0.978° 
0 1113 (60.0)  3 (0.4)  
1 527 (28.4)  446 (60.5)  
2 148 (8.0)  181 (24.5)  
3 33 (1.7)  60 (8.1)  
4 22 (1.2)  23 (3.1)  
≥5 13 (0.7)  25 (3.4)  
Miscarriage/TOP  0.285°  0.409° 
0 1176 (63.4)  375 (50.8)  
1 448 (24.1)  205 (27.8)  
2 157 (8.4)  94 (12.7)  
3 48 (2.6)  37 (5.0)  
4 20 (1.1)  14 (1.9)  
≥5 7 (0.4)  13 (1.8)  
Obstetric history  N/A  0.925° 
1 previous CS N/A  594 (80.1)  
2 previous CS N/A  114 (15.4)  
3 previous CS N/A  21 (3.0)  
4 previous CS N/A  6 (1.0)  
5 previous CS N/A  3 (0.5)  
*One-way ANOVA. °Chi-square test; N/A, not applicable; TOP, termination of 
pregnancy. Table 11: Demographic factors and obstetric history in 
relation to placental location 
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That was not the case in the control group, where anterior wall implantation was 
recorded with the highest frequency (945/1856 cases (50.9%)), followed by posterior 
wall implantation 585/1856 cases (31.5%). Low-lying anterior and posterior 
placentae occurred in low but approximately equal frequencies in both the CS group 
(1.5% and 1.4%, respectively) and control group (0.9% and 1.2%, respectively). 
 
 
Placental location 
 
Control group 
 
CS group 
Chi-
square 
test 
 Number % Number %  
Anterior 945 50.9 334 45.3 0.0093 
Posterior 585 31.5 348 47.2 <0.0001 
Fundal 287 15.5 35 4.7 <0.0001 
Low-lying Anterior 16 0.86 11 1.5 0.155 
Low-lying posterior  23 1.2 10 1.4 0.812 
 
Table 12: Frequency of different placental locations in women without 
(controls) and with previous caesarean section 
 
Comparing the frequency of placental locations between the two groups, a 
posterior placenta occurred significantly more often in the CS than in the control 
group (47.2 versus 31.5%; P < 0.0001), while fundal placental locations were 
encountered significantly more often in the control group (15.5% versus 4.7%; P < 
0.0001). Agreement on placental location between two independent operators was 
obtained in 45/49 cases (91.8%). 
 
Placental migration of low-lying placental subtypes 
A low-lying placenta (anterior and posterior) was recorded at 12 weeks in 21/738 
cases (2.8%) of the CS group and in 39/1856 cases (2.1%) of the control group. In 
the CS group 13/21 cases (61.9%) of the low-lying subtypes underwent migration 
at 20–32 weeks’ gestation and became non-low-lying placentae. In the control 
group placental migration was noted in 25/39 cases (64.1%) at 20 – 32 weeks. No 
statistically significant difference was found when comparing locations of the low-
lying subtypes between the two groups at 20 and 32 weeks (P = 0.79 and 0.73, 
respectively) (Table 13). 
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Table 13: Numbers of low-lying placentae in across the three trimesters, 
illustrating women without (controls) and with previous caesarean section 
migration 
 
Discussion: 
We have shown that there is a significant difference in placental location when there 
is a CS scar present on the uterus. Women with a previous history of CS are 
significantly less likely to have a fundal placenta and more likely to have the placenta 
located on the posterior wall of the uterus in a subsequent pregnancy. As expected 
there were more low-lying placentas in the CS group, however no difference was 
seen in the prevalence of anterior or posterior placentas in the low-lying group. Our 
data also suggest that the presence of a CS scar does not influence placental 
migration in the event of a low-lying placenta.  
 
Our observations suggest that the presence of a CS scar influences placentation. 
However, the significance of this observation is not clear. There are various possible 
mechanisms that may be playing a role. The presence of a section scar might alter 
myometrial contractility and so disrupt the normal contraction waves seen in the 
endometrium	   82. In addition, disruption of the junctional zone of the uterus may also 
be a contributing factor. Finally uterine scarring may have a deleterious effect on 
decidualisation, a process that occurs in all species where implantation causes 
breaching of the luminal endometrial epithelium 39. There is a growing body of 
evidence to suggest that compromised placental development and its subsequent 
effects on pregnancy outcome are caused by impaired decidualisation 37. Should the 
presence of a CS scar compromise decidualisation quality, this may have 
implications for both potential fertility, the likelihood of spontaneous miscarriage as 
well as placental development. This concept seems plausible especially as research 
is increasingly focusing on the uterine inflammatory response and its association 
with successful implantation.  
 
Placental location CS group 12 weeks 20 weeks 32 weeks 
Low lying Anterior and Posterior (n) 21 13 9 
Placental location control group 12 weeks 20 weeks 32 weeks 
Low lying Anterior and Posterior (n)  39 25 12 
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In relation to the other variables, we found in the control group that maternal age had 
an effect on placental location. Older women had significantly more low-lying 
placentas. This is in agreement with studies by Ananth (1996) and Matsuda (2011)	  83	  83,84, although we were unable to confirm their observation that parity, ethnicity,  and 
a short inter pregnancy interval were associated with low-lying placentation 83.  
 
A strength of our study is that it was prospective and carried out on a relatively large 
sample size. A limitation lies in the initial scan being undertaken at around 12 weeks, 
when the placenta is known to subsequently migrate 46. Furthermore, we did not 
perform a formal inter-observer variability analysis on our definition of a low-lying 
placenta. This highlights the fact that there is no “gold standard” against which to 
judge the ultrasound-based assessment of placental location. However our data 
suggests there is close agreement between observers regarding placental site at the 
12 week and 20 week scan.  
 
Our study confirms that a previous CS may have a significant impact on placental 
location in subsequent pregnancies.  The mechanism behind this effect is not clear, 
however this observation may provide indirect evidence that the presence of a CS 
scar in the uterus has a more global effect on the endometrium than the physical 
presence of a scar in isolation.  
 
3.4   Changes in caesarean section scar dimensions during 
pregnancy: a prospective longitudinal study 
 
Objectives: 
To describe the changes in caesarean section (CS) scars longitudinally throughout 
pregnancy, and relate initial scar measurements, demographic and obstetric 
variables to subsequent changes in scar features and the final pregnancy outcome. 
Between June 2010 and July 2011, 389 non-selected consecutive pregnant women 
were enrolled in the study. We included women with singleton gestations who had 
undergone at least one previous low-transverse CS. Women with multiple gestations 
(n=19) and those with a history of a classical CS (n=11) were excluded from the 
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study. Thirteen cases had a mid-trimester spontaneous miscarriage, 17 cases 
withdrew from the study after subsequent scans and 9 cases were lost to follow up. 
The final study cohort consisted of 320 women who were examined using and 
applying the ultrasound system specifications and image optimization as explained 
in sections 2.3.1 and 2.3.2 above.  
 
All participating women underwent TVS at 11-13, 19-21 and 32-34 weeks gestation 
coinciding with their routine nuchal, anomaly and growth scans when possible. At the 
first scan visit, demographic data were recorded and an obstetrics and medical 
history was obtained. This included the number of previous CS and if any were 
complicated by post partum haemorrhage or infection. The operators performing the 
scans were blind to this clinical information. 
 
The delineation and measurements of the CS scar using ultrasound were carried out 
according to methods described in sections 2.3.3-5 above (Figure 10). The lower 
uterine segment was assessed using ultrasonography in real time to identify the area 
likely to contain the CS scar. The scar has been assessed by a two-segment 
approach; a hypoechoic part or “apparent defect” and the scar contained in any 
residual myometrium, which for measurement purposes is expressed as the residual 
myometrial thickness or RMT. As a relationship between scar appearances and 
function has not been shown we have used the terms hypoechoic segment and RMT 
segment to describe scar measurements. In this way we have chosen to avoid using 
the term “deficiency/defect” as a morphological descriptor.  
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Figure 10: Schematic illustration of CS scars measurements by transvaginal 
sonography ((a)= sagittal view, (b)= transverse view). A= scar width, B= scar 
depth, C= scar length, D= RMT 
 
When the scar was visible, three measurements were taken in the sagittal plane: 
scar width, depth and RMT, while scar length was measured in the transverse plane. 
This method was applied at each scan visit and the data recorded prospectively on 
an excel spreadsheet.  
 
Statistical analysis: 
The median and 25th-75th percentile for scar width, depth and length; and RMT were 
calculated for each trimester. These scar characteristics were compared over the 
three trimesters with use of one-way repeated measures ANOVA. The 
corresponding P values were corrected for multiple testing with the false discovery 
rate (FDR) approach of Benjamini and Hochberg 85.  
 
An initial graphical exploration of scar size over time suggested an approximate 
linear trend of scar dimension over time. Because the pregnancies included in our 
data set constitute a sample from the population of interest whilst we wish to draw 
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conclusions about typical scar characteristics patterns in the general population, we 
fitted mixed models per scar characteristic. Each mixed model contained two fixed-
effects parameters (the intercept and slope of the scar characteristic versus time 
trend per pregnancy), and two correlated random effects (deviations in intercept and 
slope among pregnancies). For the association of change in scar characteristics with 
demographic variables and obstetric history, interaction terms between these 
variables and time were added to the mixed models, with use of a likelihood ratio test 
to compare the fitted models with and without the interaction terms. 
 
Results: 
A total of 320 women were included in this study. The caesarean scar was visible in 
284/320 cases (89%). When the scar was deemed visible at the 12-week scan, it 
continued to be visible in 100% of cases at 20 weeks and in 272/284 cases (96%) at 
34 weeks. In the visible group (n=284), 153 cases had a history of more than one 
previous CS and therefore were assigned to have an elective repeat caesarean 
section at ≥ 39 weeks gestation. Of these, 17 cases developed premature uterine 
contractions at < 39 weeks and ended with a semi-elective CS. The remaining 136 
cases progressed beyond 39 weeks and had a repeat procedure as initially planned. 
Women in the visible group with a history of one previous CS (n= 131) were 
counselled and offered a trial of vaginal birth after caesarean section (VBAC) at ≥ 38 
weeks gestation, of which 15 cases required pre-labour CS at < 38 weeks for 
various clinical reasons, 74 cases (61%) had successful trials of labour and 42 cases 
required intrapartum emergency CS due to failed trials of labour. In the cohort of 
women selected for a trial of VBAC there were 2 and 2 cases  (0.62% and 1.5%) of 
scar rupture and dehiscence confirmed at repeating CS, respectively. The 
breakdown of the patients for both visible and non-visible groups is demonstrated in 
figure 11. Demographic data and obstetric variables relating to the women included 
in this study are shown in table 14.  
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ERCD= Elective repeat caesarean delivery, EmRCD= Emergency repeat caesarean 
delivery 
 
Figure 11: Breakdown and outcomes of the study population 
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Age (years) (median; 25th -
75th percentile) 
33 (29-36) 
BMI (kg/m2) (median; 25th -
75th percentile) 
26 (24-31) 
Other variables expressed 
as ratio (%) 
 
History of DM 12/284 (4.2) 
Chronic steroid use 12/284 (4.2) 
Smoking 
Smoker 
Ex-smoker 
Non-smoker 
 
24/284 (8.4) 
67/284 (23.6) 
193/284 (68.0) 
Obstetric history 
1 previous CS 
2 previous CS 
≥3 previous CS 
 
207/284 (72.9) 
72/284 (25.3) 
5/284 (1.8) 
Previous VBAC 35/284 (12.3) 
Previous PPI 33/284 (12.3) 
 
DM= Diabetes Mellitus, PPI= Post Partum Infection 
 
Table 14: Overview of the demographics and obstetric history of the study 
population 
 
Non-visible scars (n=36) at the 12-week scan continued to be so on subsequent 
scans. Scar visibility was related to the position of the uterus with most invisible 
scars being found when the uterus was retroverted. There were 80/320 cases (25%) 
that had more than one caesarean section; among these one patient had more than 
one visible scar. In this case measurements of the larger scar were taken. 
 
Change in scar size over time:  
Mixed modelling of scar changes over time showed an average increase of 1.8mm in 
scar width per trimester, with the actual increase ranging from 1.7 to 1.9mm with 
95% likelihood. Scar depth and scar length decreased over time, with an average 
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decrease of 1.8 and 1.9mm per trimester, respectively (95% CI [1.7 1.9] and [1.8 
2.0], respectively). Finally, RMT decreased between trimesters by on average 
1.1mm (95% CI [1.0 1.2]. The changes in scar dimensions are illustrated in figure 12 
and table 15. In the two cases of reported scar rupture, the average decrease in 
RMT was 2.7 and 2.5mm respectively. The mean RMT in these cases was 0.5mm at 
the second trimester scan, in comparison to 3.6mm for the residual cases.  
 
 
Figure 12: Mixed effects modeling of scar dimensions over time 
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Table 15: CS scar size and dimensions in each trimester of pregnancy 
 
The relationship between initial hypoechoic scar segment and RMT scar segment 
and the change in scar size seen during pregnancy:  
For the modeling of scar changes over time, the random effects representing the 
intercept and slope of the dimensions versus time relationship were considered to be 
dependent because the initial scar size may be correlated with the subsequent 
change in size throughout pregnancy. We found that the larger the initial dimensions 
of the scar, the more the scar decreased in size between all three trimesters of 
pregnancy. This association held both for the dimensions of the hypoechoic segment 
of the scar (correlation coefficients = 0.516, 0.887 and 0.904 for scar width, depth 
and length, respectively) and the RMT (correlation coefficient = 0.720).  
 
Influence of demographic variables on change in scar size:  
Throughout pregnancy, there was a trend for an enhanced scar width increase and 
scar length decrease, respectively with maternal age (with a better model fit when 
including an interaction term between age and time compared to the initial mixed 
effects models with only time as independent variable; FDR P values of the 
likelihood ratio test = 0.11; table 16). Ethnicity, BMI and a history of DM did not have 
any significant association with change in scar dimensions throughout pregnancy. 
Steroid use resulted on the one hand in a smaller decrease in scar depth (FDR P 
value 0.07) over time, but on the other hand in an enhanced decrease in RMT over 
time (FDR P value 0.08; Table 16).  
Scar size 	    Trimester 1 Trimester 2 Trimester 3 FDR P value one-way 
repeated 
measures 
ANOVA 
Scar 
width	  
Median (25th-
75th percentile)	   3.6 (3-4.7)	   5.3 (4-6.6)	   7.4 (6.1-8.9)	   <0.0001	  
Scar 
depth	  
Median (25th-
75th percentile)	  
8.3 (6.6-10.2)	   6.2 (5.1-7.5)	   4.8 (3.7-5.6)	   <0.0001	  
Scar 
length	  
Median (25th-
75th percentile)	  
10.4 (8.6-12.7)	   8.0 (7.2-9.9)	   6.8 (5.9-8.1)	   <0.0001	  
RMT	   Median (25th-
75th percentile)	  
5.3 (4.7-6.2)	   3.5 (2.8-4.2)	   3.5 (2.5-3.6)	   <0.0001	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Scar size Variable 
of 
interest 
Mixed model P 
value 
FDR P 
value 
Scar width Age y = 2 + 1.83 x T   
y = 2 + 1.12 x T + 0.02 x T x V 0.024 0.11 
Scar 
length 
Age y = 12.8 – 1.96 x T   
y = 12.8 – 1.48 x T – 0.015 x T 
x V 
0.045 0.11 
Scar depth Steroid 
use 
y = 10.4 – 1.87 x T   
y = 10.4 – 1.89 x T + 0.45 x T 
x V 
0.015 0.07 
RMT Steroid 
use 
y = 6.34 – 1.13 x T   
y = 6.34 – 1.12 x T – 0.22 x T 
x V 
0.032 0.08 
Scar depth VBAC y = 10.4 – 1.87 x T   
y = 10.4 – 1.85 x T – 0.22 x T 
x V 
0.042 0.066 
Scar 
length 
VBAC y = 12.8 – 1.96 x T   
y = 12.8 – 1.93 x T – 0.23 x T 
x V 
0.026 0.066 
RMT VBAC y = 6.34 – 1.13 x T   
y = 6.34 – 1.14 x T + 0.15 x T 
x V 
0.019 0.066 
* T = trimester = 1, 2 or 3 for first, second and third trimester, respectively; V = 
variable of interest 
Table 16: Influence of demographic variables and obstetric history on scar 
characteristics throughout pregnancy 
 
Influence of previous obstetric history on change in scar size:  
Scar depth and scar length were found to decrease more rapidly over time in women 
who already had a previous successful trial of VBAC (FDR P values of the likelihood 
ratio test = 0.066). The opposite trend was observed for RMT, with less decrease 
over time in cases of a previously successful VBAC (FDR P value 0.066). When a 
multivariate analysis was carried out to investigate the influence of both maternal 
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age and a previous successful trial of VBAC on scar changes throughout the course 
of the pregnancy, they were found to enhance the decrease in scar length 
independently from each other (FDR P values of the likelihood ratio test = 0.14). On 
the other hand, change in scar width was significantly influenced by maternal age. 
Adding VBAC to the model, however, did not improve the change pattern. Similarly, 
change in scar depth and RMT were significantly influenced by VBAC, with no 
complementary contribution from maternal age. No significant association was found 
between scar size, the number of previous CS, or post partum infection.  
 
Discussion: 
We have shown that the dimensions of CS scars are not static, and that they change 
in a similar way over the course of pregnancy in the majority of women. We have 
observed that the larger the hypoechoic “apparent defect” in either the first or second 
trimester of pregnancy the smaller the dimensions of the scar become over the 
course of the remainder of the pregnancy. The same relationship holds for RMT. Our 
data also show that in women with a previous successful VBAC the hypoechoic 
“apparent defect” of CS scars is smaller whilst the RMT is larger. Our observations 
establish the natural history of both the hypoechoic “apparent defect” and RMT 
segments of CS scars that can be visualised using ultrasound.  
 
To date the focus in the literature has been on the appearance of CS scars in the 
non-pregnant state or on single assessments of scar size or morphology 22. 
However, our study shows for the first time that the size of both the hypoechoic 
segment of CS scars and the RMT change as the pregnancy progresses.  
Accordingly, any interpretation of scar morphology and size as well as changes in 
scar size must take into account the gestation when any observations are carried 
out.  
 
The strengths of the study are the relatively large sample size and the prospective 
design of the study. A weakness is that for 11% of scans the scar was not visible to 
the operators. It seems likely that a poorly visible scar has an absent hypoechoic 
“apparent defect” and a corresponding larger RMT. Of the 36 cases where the scar 
was not visible, the uterus was retroverted in the majority, while the scar was almost 
always visible when the uterus was anteverted. This discrepancy may relate to 
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tension being put on the scar by the position of the uterus, when retroverted the 
internal cavity surface of the lower segment is brought together, and a smaller scar 
may result, hence limiting their visibility. From a practical clinical viewpoint, this study 
was performed to fit in with routine clinical management i.e. at the time of the nuchal 
translucency measurement in the first trimester and fetal biometry and anomaly 
screening in the second trimester. The time slot was not increased to accommodate 
the additional transvaginal ultrasound scans and so the addition of a TVS in this 
context would be unlikely to add significantly to a unit’s workload.  
 
Our data showed that the scar length was significantly lower in women with previous 
VBAC, whilst the RMT was larger. On the other hand there were 2 cases of uterine 
scar rupture and 2 cases of dehiscence in the group of women who had a trial of 
VBAC. It is interesting to note that the two scar rupture cases had one previous CS 
and were offered a trial of VBAC. However, both underwent an emergency CS for 
suspected uterine scar rupture that was confirmed intra-operatively. In retrospect, 
these cases demonstrated different RMT changes than the rest of the cohort. They 
both had an RMT of 0.5mm at the second trimester, and a rate of change in RMT 
between the first and second trimesters of 2.7mm and 2.5mm, respectively. This 
difference is important, as these cases could have been identified as a high risk of 
failing a trial of VBAC from as early as 20 weeks gestation.  
 
The change in the different segments of CS scars observed over the course of 
pregnancy offers a novel potential approach to evaluating scar integrity. This may be 
helpful as the use of single parameters may be problematic. It was reported 
previously that LUS thickness of <2.3mm is associated with a higher risk of complete 
uterine rupture 61 and in a systematic review by Jastrow and colleagues (2010) on 
the diagnostic accuracy of measurements of the lower uterine segment by 
ultrasound at 36-39 weeks gestation to predict uterine scar rupture, they found that 
the optimal cut-off values for partial thickness ranged from 1.4mm to 2.0mm. 
However, due to the heterogeneity of the studies they included in the review, they 
were unable to recommend ideal cut-off values to be used in practice 23.  
 
We have previously shown that there is a good inter-observer agreement for 
measurement of both the hypoechoic and RMT segment of CS scars in all three 
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trimesters of pregnancy. Therefore, should either the scar measurements at a 
specific gestation or the rate of change in scar size be a predictor of scar integrity, it 
may be possible to develop a reproducible ultrasound-based test that might 
contribute to the selection of women for a trial of VBAC. A prospective study to 
evaluate the relationship between these ultrasound features and scar performance in 
labour is needed to answer this question. 
  
It is interesting to note that smoking, infection following a previous CS, and the 
number of previous CS had no significant effect on scar dimensions, although these 
factors might be expected to affect scar healing 86. However, we found that older 
women tend to have larger scars. It is well known that the physiological changes 
associated with aging place the older patients at higher risk of poor wound healing 
87, and that reduced skin elasticity and collagen replacement influence wound 
recovery 13.  
 
Age also had a significant impact on scar features during the pregnancy. Scar length 
became smaller over the course of the pregnancy the greater the age of the patient. 
Steroid use led to less decrease in scar depth but a faster decrease in RMT. 
Interestingly there was a significant difference in the change seen in RMT between 
women with a successful VBAC in the past and the rest of the study group. The 
overall decrease in absolute RMT measurements throughout pregnancy was less in 
women who had undergone a previous successful VBAC, although the scar 
dimensions decreased more rapidly in this group. These observations may shed light 
on the mechanism of CS scar integrity. A reduction in the size of the hypo-echoic 
“apparent defect” may imply scar weakness or not. The suggestion that RMT 
reduces less rapidly overall in women who have had a successful VBAC may 
suggest that RMT may be a more important indicator of scar integrity.  
 
Giving women a choice and control in childbirth is a significant driver in modern 
obstetrics. It is axiomatic that women’s decisions should be informed. Whilst 
achieving a vaginal delivery after a previous CS is considered the optimal outcome 
in many cases, attempting a VBAC when there is little or no chance of success, may 
not be an option a woman would want to take. Furthermore predicting serious 
complications such as rupture and dehiscence is important because of the 
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accompanying morbidity. We have described reference data relating to CS scars 
throughout pregnancy. Our observations also suggest that the RMT remains 
relatively static and thicker in women who have had a successful VBAC in the past. 
Conversely the opposite was true in the small number of adverse scar outcomes in 
the group. These changes could be observed as early as twenty weeks gestation. 
These findings support the view that absolute measurements and changes in scar 
size between twelve and twenty weeks gestation have the potential to be 
incorporated into algorithms used to advise women regarding the likely success of a 
trial of VBAC. 
 
3.5   Can the residual myometrial segment of a caesarean 
section scar measured by ultrasound provide an early 
prediction of scar performance at repeat caesarean delivery? A 
prospective longitudinal study 	  
Objectives: 
To predict caesarean scar appearance assessed by the surgeon at grade 1, 2 and 3 
repeat caesarean section (CS) from sonographic features of the residual myometrial 
thickness (RMT) obtained throughout pregnancy.  
The same patients as outlined in the study design in figure 11 in the previous 
chapter were used to conduct this study. Study 4 has been used to develop 
reference data relating to the changes in CS scar size seen over the course of 
pregnancy and their clinical significance on the final pregnancy outcome. Delineation 
and measurements of the CS scar and the RMT by ultrasound were carried out 
according to methods described in sections 2.3.3-5 above (Image 6, Figure 10). 
When the scar was visible, mean scar size (MSS) with the formula (width+ depth+ 
length)/3 was calculated in addition to measuring the RMT. These measurements 
were carried out at 11-13, 19-21 and 32-34 weeks gestation. Data were entered 
prospectively on an excel spreadsheet and patients followed into the final delivery 
outcome.  
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From this cohort, patients who needed to deliver by a repeat CS (Figure 11) were 
classified based on the urgency of the delivery and in accordance with the United 
Kingdom National Confidential Enquiry into Patient Outcome and Death (NCEPOD) 
criteria 68. Three categories were adopted with modification from NCEPOD and as 
follows: 
Grade 1: Emergency/ intrapartum CS. 
Grade 2: Semi-elective/ prelabour CS. 
Grade3: Elective/ scheduled CS.  
For the purpose of this study, we will be referring into the different groups of patients 
in this study as grade 1, 2 and 3.  
 
At repeat CS, four scar descriptions were agreed on by the research team together 
with the clinician in charge of labour ward as follows (Images 14-17): 
 
Thick: Old scar is difficult to visualize, no defect palpable through the LUS. 
Thin: Old scar is easy to visualize, defect palpable at any scar point in the LUS. 
However, uterine contents not visible within, intact peritoneum. 
Dehisced: Partial gaping at any scar point in the LUS, uterine contents, including 
liquor or fetal presenting part are visible, and intact peritoneum. 
Ruptured: Complete gaping at the inner and outer edges of the scar in the LUS, 
peritoneum disrupted allowing direct access to the uterine cavity. 
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Image 14: Difficult to visualize the probable location of CS scar in the lower 
uterine segment  
 
 
Image 15: Easy to visualise ‘thin’ CS scar 
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Image 16: Partial gaping at the ‘dehisced’ CS scar 
 
 
 
Image 17: Complete gaping at the ‘ruptured’ CS scar  
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In order to develop the accuracy of intra-operative classification of the scar types, a 
pilot trial using the agreed scar descriptions was initially carried out on 18 caesarean 
sections. Photographs of scars classified as being thick, thin and dehisced were 
crosschecked against the agreed definitions with the operating surgeon and 
members of the research group. The agreed pictures were placed in the operating 
theatre of the delivery suite for reference. These pilot cases were not included in the 
subsequent study and analysis.   
 
Patients enrolled in the study had a numbered slip placed on their medical records 
so that theatre staff could identify them and alert the operating surgeon to describe 
the old CS scar against the reference pictures present in the operating room. The 
operating surgeons were blind to the ultrasound features of the scar when making 
their assessment. The intra-operative scar findings were entered on the same 
database of the corresponding ultrasound findings as an outcome measure. We then 
tested the sensitivity and specificity of different cut-off values for MSS and RMT for 
predicting the scar appearance at surgery. 
 
Statistical analysis: 
Descriptive analysis was used to demonstrate the breakdown of the scar 
appearance in both the visible and non-visible scar groups and according to the 
grade of repeat CS. Univariate analyses by non-parametric Kruskal Wallis test, and 
Wilcoxon rank sum test for continuous variables, are used for associating scar 
appearance with RMT/ MSS at trimester 1, 2 and 3. For RMT and MSS, median (and 
10th -90th percentile range) measurements are provided per scar appearance at all 
three trimesters. Sensitivity, specificity, positive predictive value and negative 
predictive value are provided for the prediction of defects (dehisced or ruptured 
scars) based on RMT measurements at any of the three trimesters.  
 
For the association of scar appearance with change in RMT and MSS throughout 
pregnancy, a mixed model was opted for with two fixed-effects parameters. The 
intercept (a) and slope (b) for RMT/MSS versus trimester (T) and two correlated 
random effects for deviations in intercept and slope among individuals. For the 
association of change in RMT/MSS with scar appearance, scar appearance (SA) 
and the interaction term between SA and T were added to the mixed model, with use 
	   84	  
of a likelihood ratio test to compare the fitted models with and without the SA and 
interaction term. Model: RMT/MSS = a + b x T + c x SA + d x T x SA.  
 
Results: 
A total of 320 women were included in this study. The caesarean scar was visible in 
284/320 cases (89%). The breakdown of the patients for both visible and non-visible 
groups is demonstrated in figure 11. In the visible group thin scars observed more 
frequently than thick scars (39.7% versus 31.6% respectively), while in the non-
visible group thick scars occurred with the highest frequency (33.3% versus 19.4% 
respectively). Dehisced and ruptured scars occurred in 5 and 2 cases of the visible 
group respectively, whilst none were seen in the non-visible group (Table 17).  
Scar appearance Thin Thick Ruptured Dehisced 
Visible scar (n=284) 113 90 2 5 
Non-visible scar (n=36) 7 11 0 0 
Total (n=320) 120 101 2 5 	  
Table 17: Breakdown of four scar types among the visible  
and non-visible CS scar groups 	  
In the visible scar group (n=284), 47 cases ended with grade 1 repeat CS while 27 
and 136 cases ended with grade 2 and 3 repeat CS respectively. As grade 2 CS was 
performed in only 27 cases, the focus of this study will be at grade 1 and 3 groups. 
 
There was a significant difference in scar appearance for both grade 1 and 3 groups. 
In grade 1, the vast majority of the cases had thin scar (41/47), while in grade 3 thick 
scars were recorded with the highest frequency (78/136) (P <0.05) (Table 18). 
 
Scar appearance for 
visible scars (n=284) 
Thin Thick Ruptured Dehisced 
Grade 3 CS (n=136) 55 78 0 3 
Grade 2 CS (n=27) 17 10 0 0 
Grade 1 CS (n=47) 41 2 2 2 
Total (n=284) 113 90 2 5 
  
Table 18: Breakdown of four scar types in the visible group according to 
the grade of repeat CS 	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The corresponding values of RMT and MSS across all trimesters in the grade 3 
repeat CS group are demonstrated in table 19. In all scar types of that group, the 
RMT decreased between the 1st and 3rd trimesters. However, the RMT had a less 
gradual decrease for the thick scars in comparison to the thin and dehisced scars 
(from 5.2mm in trimester 1 to 3.6mm in trimester 3 in thick scars, from 5.9mm to 
2.4mm in thin scars and from 4.5mm to 1.2mm in dehisced scars, respectively). In 
addition, it is interesting to note that RMT but not MSS at trimester 1, 2 and 3 was 
significantly different in relation to the type of scar appearance (Figure 13).  
 
            Median CS values with 10th-90th-percentile range 
 
Scar 
measurement 
(mm) 
 
Thin 
 
Thick 
 
Dehisced 
 
P value Kruskal 
Wallis test* 
RMT T1 5.91 (4.9-7.1) 5.22 (4.2-6.6) 4.49 (4.0-5.0) <0.0001 
RMT T2 2.73 (2.4-3.2) 4.1 (3.7-5.5) 1.8 (1.6-2.1) <0.0001 
RMT T3 2.45 (2.4-2.7) 3.65 (3.5-4.1) 1.2 (1.1-1.5) <0.0001 
MSS T1 7.71 (6.1-10.7) 7.58 (6.1-10.2) 8.02 (6.6-11.1) 0.917 
MSS T2 6.75 (5.5-8.4) 6.95 (5.5-8.8) 6.57 (6.5-7.3) 0.777 
MSS T3 6.19 (5.2-7.8) 6.51 (5.4-8.3) 6.77 (6.6-6.9) 0.202 
 
* Significance of the difference in mean scar measurement at each trimester 
across the scar appearance types. T: trimester, RMT: residual myometrial 
thickness, MSS: mean scar size.  
 
Table 19: Corresponding values of RMT in relation to scar type among 
grade 3 repeat CS group  	  
For RMT, a significantly better fit for the model was obtained when adding scar 
appearance and an interaction term between scar appearance and trimester to the 
standard growth curve for RMT in function of trimester (P value likelihood ratio test 
< 0.0001) (Figure 14). Scar appearance did not have a significant influence on 
change in MSS throughout the pregnancy.  
RMT model equations (with T=1, 2, or 3 for trimester 1, 2 and 3, respectively): -­‐ Thin: RMT (mm) = 7.26 – 1.75 x T -­‐ Thick: RMT (mm) = 5.97 – 0.73 x T -­‐ Dehisced: RMT (mm) = 5.74 – 1.60 x T 	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Figure 13: Boxplots of RMT values across all trimesters in grade 3 
repeat CS	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Figure 14: Longitudinal changes in RMT between thick, thin and 
dehisced scars across trimesters in the grade 3 repeat CS group	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For the thick, thin and dehisced scar appearance in this group, we divided the 
corresponding RMT values into four different cut-offs. We then calculated the 
sensitivity, specificity, positive and negative predictive values for each cut-off as 
demonstrated in tables 20-22. For trimester 1, an RMT value of ≤ 4.81mm had the 
best combined sensitivity and specificity (66.7 and 76.7%, respectively), while in 
trimester 2 and 3, cut-offs of ≤ 2.53 and ≤ 2.40mm had a sensitivity and specificity 
of 100%, 91.7%, 100% and 100%, respectively.  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 4.31 33.3 (1/3) 90.2 7.1 98.4 
≤ 4.81 66.7 (2/3) 76.7 6.1 99.0 
≤ 5.42 100 (3/3) 51.1 4.4 100 
≤ 6.20 100 (3/3) 25.6 2.9 100 	  
Table 20: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and dehisced scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 1 as cut-off 
values in grade 3 repeat CS	  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 2.53 100 (3/3) 91.7 21.4 100 
≤ 2.80 100 (3/3) 78.9 9.7 100 
≤ 3.70 100 (3/3) 51.9 4.5 100 
≤ 4.13 100 (3/3) 26.3 3.0 100 
 
Table 21: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and dehisced scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 2 as cut-off 
values in grade 3 repeat CS	  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 2.40 100 (3/3) 100 100 100 
≤ 2.46 100 (3/3) 76.7 8.8 100 
≤ 3.5 100 (3/3) 59.4 5.3 100 
≤ 3.67 100 (3/3) 26.3 3.0 100 	  	  
Table 22: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and dehisced scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 3 as cut-off 
values in grade 3 repeat CS	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The corresponding values of RMT and MSS across all trimesters in the grade 1 
repeat CS group are demonstrated in table 23. This group comprised of cases that 
were initially selected for VBAC trials but resulted in intrapartum emergency CS 
due to failed trials for various maternal, fetal and obstetric reasons. In this group we 
had 2 cases of confirmed uterine scar rupture and 2 cases of scar dehiscence. The 
ruptured cases had lower RMT values in the first trimester in comparison to the 
thin, thick and dehisced cases (3.09mm versus 5.48mm, 4.46mm and 5.09mm, 
respectively). In addition, RMT decreased significantly in cases of uterine rupture 
across the trimesters (from 3.09mm in T1 to 0.5mm in T2 and T3), while the other 
scar types demonstrated a less gradual decrease. In this group, again RMT rather 
than MSS was significantly associated with the scar classification at surgery 
(Figure 15).  
 
Median CS values with 10th-90th-percentile range 
Scar 
measur-
ements 
(mm) 
 
Thin 
 
Thick 
 
Ruptured 
 
Dehisced 
P value 
Kruskal 
Wallis 
test* 
RMT T1 5.48 (4.4-6.8) 4.46 (3.9-5.0) 3.09 (3.0-3.2) 5.09 (5.0-5.2) 0.044 
RMT T2 2.81 (2.4-3.1) 3.92 (3.7-4.1) 0.5 (0.5-0.5) 2.1 (2.1-2.1) 0.001 
RMT T3 2.47 (2.4-2.7) 3.65 (3.5-3.8) 0.5 (0.5-0.5) 1.59 (1.3-1.9) 0.001 
MSS T1 7.35 (5.9-9.4) 8.52 (7.2-9.9) 7.88 (6.1-9.7) 8.15 (6.9-9.4) 0.889 
MSS T2 6.46 (5.1-8.7) 7.11 (6.6-7.6) 6.53 (5.4-7.7) 6.71 (6.5-6.9) 0.950 
MSS T3 6.57 (4.7-8.5) 6.77 (6.3-7.3) 6.24 (4.7-7.8) 6.44 (5.9-7.0) 0.971 	  
* Significance of the difference in mean scar measurement at each trimester 
across the scar appearance types. T: trimester, RMT: residual myometrial 
thickness, MSS: mean scar size.  
 
Table 23: Corresponding values of RMT in relation to scar type among 
grade 1 repeat CS group  	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Figure 15: Boxplots of RMT values across all trimesters in grade 1 
repeat CS	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For RMT, a significantly better fit for the model was obtained when adding scar 
appearance and an interaction term between scar appearance and trimester to the 
standard growth curve for RMT in function of trimester (P value likelihood ratio test < 
0.0001) (Figure 16). Scar appearance did not have a significant influence on change 
in MSS throughout the pregnancy. 
RMT model equations (with T=1, 2, or 3 for trimester 1, 2 and 3, respectively): -­‐ Thin: RMT (mm) = 6.75 – 1.54 x T -­‐ Thick: RMT (mm) = 4.83 – 0.41 x T -­‐ Dehisced: RMT (mm) = 6.43 – 1.75 x T -­‐ Ruptured: RMT (mm) = 3.95 – 1.29 x T 	  	  
	  	  	  
Figure 16: Longitudinal changes in RMT between thick, thin, dehisced 
and ruptured scars across trimesters in the grade 1 repeat CS group	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For grade 1 CS group of the thick, thin and ruptured scar appearances; we also 
divided the corresponding RMT values into four different cut-offs. The sensitivity, 
specificity, positive and negative predictive values for each cut-off is demonstrated 
in tables 24-26. For trimester 1, an RMT value of ≤ 3.71mm had sensitivity of 50% 
and specificity of 93%, while in trimester 2 and 3, cut-offs of ≤ 2.42 and ≤ 2.40mm 
had sensitivity and specificity of 100%, 97.7%, 100% and 100%, respectively.  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 3.71 50 (2/4) 93.0 40.0 95.2 
≤ 4.83 50 (2/4) 76.7 16.7 94.3 
≤ 5.46 100 (4/4) 55.8 17.4 100 
≤ 6.35 100 (4/4) 27.9 11.4 100 
 
Table 24: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and ruptured scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 1 as cut-off 
values in grade 1 repeat CS	  	  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 2.42 100 (4/4) 97.7 80.0 100 
≤ 2.56 100 (4/4) 86.0 40.0 100 
≤ 2.80 100 (4/4) 55.8 17.4 100 
≤ 3.04 100 (4/4) 27.9 11.4 100 
 
Table 25: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and ruptured scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 2 as cut-off 
values in grade 1 repeat CS	  	  	  
Cut-off Sensitivity Specificity PPV NPV 
≤ 2.40 100 (4/4) 100 100 100 
≤ 2.41 100 (4/4) 83.7 36.4 100 
≤ 2.47 100 (4/4) 58.1 18.2 100 
≤ 2.57 100 (4/4) 27.9 11.4 100 	  	  
Table 26: Sensitivity, specificity, PPV and NPV for prediction of thick, 
thin and ruptured scar appearance with use of 10th percentile, 25th 
percentile, median and 75th percentile of RMT at trimester 3 as cut-off 
values in grade 1 repeat CS	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Discussion:  
We have shown in this study that the ultrasound features of the CS scar measured 
during the course of the pregnancy could potentially translate the actual surgical scar 
appearances described at repeat caesarean delivery. MSS measured at any point in 
pregnancy did not have a significant association with subsequent scar appearance 
at surgery. However, single measurements of RMT did relate to the 4 scar types 
seen at surgery across all trimesters for both grade 1 and 3 repeat CS. In addition, 
changes in RMT between trimester 1 and 2 and between trimester 2 and 3 were also 
significantly different for each of the four scar appearances.  
 
We described the natural history of CS scars in pregnancy in study 4 and showed 
that both the cystic and RMT segments of the scar are not static, and that they 
change independently over the course of pregnancy in the majority of women. We 
have also observed that the larger the hypoechoic and the RMT segments in either 
the first or second trimester of pregnancy, the smaller the dimensions of the scar 
become in the remainder of the pregnancy. Accordingly, any interpretation of scar 
morphology and size, or their changes over time must take into account the 
gestation when any observations are carried out. It is possible that should any of the 
scar segments increase or decrease rapidly, then this may be associated with a 
relatively weak scar and can have an impact on subsequent scar performance in 
labour. Therefore it may be clinically important to obtain longitudinal data for the scar 
features in pregnancy, as the use of single parameters may not give the complete 
picture of scar integrity. In this study, there was a downward trend in RMT over the 
course of pregnancy, and this fall was greatest in dehisced and ruptured scars in 
comparison to thin and thick scars. In the grade 1 CS group, mean RMT change for 
thick scars was 0.98mm between T1 and T2 and 0.38mm between T2 and T3 (P 
value 0.048), whilst in the grade 3 CS group, the mean RMT was 0.96mm between 
T1 and T2 and 0.88mm between T2 and T3 (P value 0.02).  
 
In order to appropriately counsel pregnant women about the clinical outcome of a 
scarred uterus, it is important to have evidence regarding early prediction of uterine 
scar rupture or performance to prevent this serious complication, and to allow 
women time to think through their options and prepare for the likely mode of delivery. 
In our prospective study we aimed to predict scar appearance described for different 
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grades of repeat caesarean delivery from as early as 12 weeks gestation; based on 
the corresponding scar features obtained by ultrasound at any of the trimesters or 
based on change in scar measurements during pregnancy. Based on our data, the 
highest accuracy of predicting uterine scar ruptures in grade 1 repeat CS can be 
predicted from as early as the second trimester. In this group, an RMT cut-off of ≤ 
4.83 had 50% sensitivity and 76.7% specificity for the prediction of scar rupture in 
the first trimester, whilst in the second trimester a cut-off of ≤ 2.42mm gave a 
sensitivity of 100% specificity of and 97.7% for the prediction of scar rupture. We 
highlighted in study 1 above the importance of RMT as a predictor of scar integrity in 
subsequent pregnancy. Bujold and colleagues conducted a study to assess the risk 
of uterine scar rupture in pregnant women at 35-38 weeks gestation. They reported 
when the LUS thickness is less than 2.3mm it is associated with a higher risk of 
complete uterine rupture 61. However it is important to be aware that this study was 
conducted in late gestation when it is known that descent of the fetal presenting part 
starts to compress the lower uterine segment. This may limit the utility of ultrasound 
for the assessment of the LUS at this gestational age. On the other hand, Jastrow 
and colleagues carried out a systematic review on the diagnostic accuracy of 
measuring the lower uterine segment by ultrasound to predict uterine scar rupture; 
they found that the cut-off values for the muscular thickness of the LUS is ranged at 
1.4-2.0 mm. However, due to the heterogeneity of the studies they included in the 
review, they were unable to recommend ideal cut-off values to be used in practice	  23.  
Establishing an ideal cut-off would seem difficult giving the difference in scar 
appearance at repeat CS. However, our data provide a platform for future studies to 
confirm the validity of ultrasound in predicting subsequent scar performance from as 
early as 20 weeks gestation.  
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3.6   Predicting successful vaginal birth after caesarean section 
using a model based on caesarean scar features examined 
using transvaginal sonography 
 
Objectives: 
To develop a model to predict the success of a trial of vaginal birth after caesarean 
section (VBAC) based on measurements of caesarean section scar features using 
ultrasound, demographic variables and previous obstetric history.  
 
The same dataset as described for study 4 was used to conduct this study. All 
women in this cohort with a history of one previous CS were considered suitable for 
a trial of VBAC and referred to a specialized VBAC clinic where appropriate 
counselling was offered (Figure 11). Women with ≥ 2 previous CS were all booked 
for an elective CS as per hospital policy.  
 
Ultrasonography was carried out at 11-13, 19-21 and 32-34 weeks gestation. The 
delineation and measurements of the CS scar using ultrasound were carried out 
according to the methods described in sections 2.3.3-5 above (Figure 10). A scar 
was defined as being visible when it showed a hypoechoic indentation representing 
myometrial discontinuity at the anterior wall of the lower uterine segment, with or 
without underlying residual myometrium.  
 
Scar measurements were added at subsequent visits in the second and third 
trimester, and patients were followed up until the final pregnancy outcome was 
known. Clinicians responsible for the care of these women in labour were blind to the 
ultrasound features of the caesarean scar. All data were entered weekly to a 
designated research database and were checked for missing, out of range, and 
inconsistent values. For the purposes of this study, uterine scar rupture was defined 
as mentioned in section 3.5 above as a complete gaping at the inner and outer 
edges of the scar in the LUS, peritoneum disrupted allowing direct access to the 
uterine cavity	  68.  
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Statistical analysis: 
The factors considered for use in the predictive model were selected on the basis of 
experts’ opinion. These included two demographic variables (patients’ age and pre-
pregnancy BMI), one variable related to previous obstetrics history (prior successful 
VBAC) and two CS scar variables (the RMT measured at the second trimester and 
the change in RMT between the first and second trimesters (ΔRMT)). A logistic 
regression model was built. Because the sample size was small relative to the 
number of predictors, penalized maximum likelihood based on the corrected 
Akaike’s Information Criterion (AIC) was used to obtain reliable regression 
coefficients for prediction 88. We did not find nonlinear predictor effects or outliers, 
nor did we detect strong relationships among the predictors.   
 
The area under receiver-operating characteristic curve (AUC) and the sensitivity and 
specificity (at a range of cut-off values) were computed to assess the discriminative 
performance. A calibration plot was made to investigate the agreement between 
observed and predicted probabilities. The clinical utility of the model was assessed 
with decision curves that plot the net benefit for a range of cut-off values for 
predicted probability 89	  90. A cut-off of 0.7 was often used in earlier studies 69. Using 
this methodology, the clinical utility of a model at a given cut-off to classify patients 
as suitable for vaginal delivery is quantified as the net benefit, which is calculated as 
the difference between the proportion of true positives and the proportion of false 
positives weighted by the odds of the probability cut-off. The odds of the cut-off value 
represents the relative misclassification cost, with a value above 1 indicating that an 
emergency CS (i.e. a false positive) is worse than is an unnecessary elective CS 
(i.e. a false negative). For example, using a probability cut-off of 0.7 implies a weight 
of 0.7/0.3. = 2.3, such that avoiding one emergency CS is worth 2.3 unnecessary 
elective CS deliveries.  
 
A model has clinical utility at a given cut-off if its net benefit is higher than the net 
benefit of two default strategies for which no model is needed: in this case 
attempting vaginal delivery in all patients or performing elective CS in all patients. 
The desired cut-off (of probability of success) in order to attempt vaginal delivery, 
and thus the relative importance of false-positives and false-negatives, is not the 
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same for every clinician or patient. We therefore investigated the relevant range 
between 0.3 and 0.9, and plotted the results in a decision curve.  
 
To validate the prediction models internally we did not split the data into training and 
test sets due to the limited sample size; instead, the regular bootstrap was used to 
estimate performance on new patients 91	  92.  
 
Analyses were performed using R (http://www.r-project.org/; R Foundation, Vienna, 
Austria). The ‘rms’ package was used to obtain the logistic regression model; the 
penalized coefficients, the AUC and the calibration plot 88.  
 
Results: 
The CS scar was visible in 284/320 (89%) cases. Of the 36 women in whom the scar 
was not visible, 22 had undergone one previous CS and, of these, 18 (82%) 
subsequently had a successful vaginal delivery. As the ‘non-visible scar’ group did 
not have measurable scar features, subsequent analysis in this section is focused on 
the ‘visible scar’ group.  
 
The average birth weight was 3170 gram in the cases of failed VBAC and 3410 gram 
in the successful group. This difference is statistically significant (df=66.386, t=-2.18, 
P 0.03) (Figure 17). The mean gestational age at delivery was 38+5 (median, 39) 
weeks in the failed VBAC group and 40+1 (median, 40) weeks in the successful 
VBAC group. The difference between these two groups is also statistically significant 
(Wilcoxon=1959.00, Z=-4.36, p=<0.0001) (Figure 18).  
 
However there was no difference between the likelihood of spontaneous onset of 
labour between the two groups. A total of 30/47 (65%) cases in the failed and 57/74 
(80%) cases in the successful VBAC group went into spontaneous labour, with 
labour induced in the remaining women. Due to the relatively small numbers we 
were unable to ascertain any significant differences between the use of 
prostaglandins and syntocinon between the successful and unsuccessful VBAC 
groups, although syntocinon was more likely to be used in the failed trials. 	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Figure 17: Distribution of birth weight between successful and failed 
VBAC groups 
 
 
Figure 18: Distribution of gestational age (GA) between successful and 
failed VBAC groups 
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In the visible scar group (n= 284), 153 women had a history of more than one 
previous CS and were therefore assigned to have an elective CS at ≥ 39 weeks’ 
gestation; these women were excluded from development of the prediction model. 
Women with a history of one previous CS and visible scar (n=131) were offered a trial 
of VBAC. Fifteen women were subsequently excluded because they underwent CS 
prior to labour due to various causes. Of the remaining 116 cases, successful VBAC 
was achieved in 74 (61%), while 42 cases had failed trials of labour that resulted in an 
intrapartum emergency CS. The indications for CS in the failed VBAC group are 
shown in table 27. Around 80% were for fetal distress, failure to progress or 
suspected scar rupture.     
                          
Indication  N (%) 
CS scar rupture 2 (4.3) 
Antepartum haemorrhage 2 (4.3) 
Fetal distress 14 (29.8) 
Fetal distress secondary to 
abruption 
1 (2.1) 
Failure to progress 20 (42.6) 
PET/GDM/PROM 2 (4.3) 
Placental abruption 1 (2.1) 
 
Table 27: Indications for emergency CS in 47 women with visible CS 
scar and one previous CS, who attempted vaginal birth after caesarean 
section. GDM, gestational diabetes mellitus; PET, pre-eclamptic 
toxemia; PROM, premature rupture of membranes	  
 
Descriptive statistics for other variables are illustrated in table 28. Bivariate descriptive 
showed the median RMT in the second trimester was higher for patients who 
subsequently underwent a successful VBAC than for patients with a failed VBAC 
(4.2mm versus 2.8mm, respectively) and the median difference in RMT between the 
first and second trimester was lower for women with a successful VBAC than for 
women with failed trials of labour (0.8mm versus 2.8mm, respectively) (Figures 19, 
20).  
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Figure 19: Distribution of second trimester RMT by mode of delivery 
between successful and failed VBAC groups 
 
 
Figure 20: Distribution of RMT change from second to third trimester 
by mode of delivery between successful and failed VBAC groups 
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Parameter Failed VBAC 
(n=42) 
Successful VBAC 
(n=74) 
Age (years) 33 
(20, 28, 35, 43) 
32 
(21, 29, 34, 39) 
Body mass index (kg/m2) 25 
(19, 23, 29, 40) 
27 
(18, 24, 30, 41) 
Previous VBAC 3 (6.4) 25 (33.8) 
RMT (mm)   
First trimester 5.5 
(3.0, 4.8, 6.4, 9.1) 
5.9 
(2.8, 3.5, 5.9, 7.6) 
Second trimester 2.8 
(0.5, 2.6, 3.1, 4.2) 
4.2 
(2.6, 3, 4.6, 6.3) 
Third trimester 2.5 
(0.5, 2.4, 2.6, 3.8) 
3.6 
(3.2, 2.6, 3.9, 5.9) 
ΔRMT: second trimester–first 
trimester (mm) 
2.8 
(0.1, 2.1, 3.4, 6.2) 
0.8 
(0.1, 0.4, 1.2, 4.7) 
GA at delivery (weeks) 39 
(31, 38, 40, 42) 
40 
(38, 40, 41, 42) 
Birth weight (g) 3170 
(1495, 2926, 3600, 4756) 
3488 
(2420, 3125, 3700, 4540) 
Spontaneous onset of labor 30 (65.2) 57 (80.3) 
Use of Syntocinon 12 (26.1) 2 (2.8) 
Use of prostaglandin 9 (19.6) 8 (11.3) 
 
Table 28. Descriptive statistics of patient, scar, labour and birth weight 
characteristics according to mode of delivery in 121 women with visible 
CS scar and one previous CS. Data given as media (minimum, 1st 
quartile, 3rd quartile, maximum) or n (%)  
 
In a logistic regression model including age, BMI, RMT, ΔRMT and previous VBAC, 
BMI had a small, but statistically non significant, positive effect on the chance of 
successful vaginal delivery and did not discriminate between successful and failed 
trials (OR=0.8, p=0.23). This effect is contrary to findings in the literature 69 and was 
excluded from the prediction model to enhance generalisability. 
 
The fitted logistic regression model suggests that the chance of a successful VBAC 
increases with larger second-trimester RMT (OR = 6.26 per mm, P =0.0009). In 
addition, the greater the decrease in ΔRMT, the lower the probability of a successful 
VBAC (OR = 0.25 per mm, P <0.0001). Although not statistically significant, the effect 
of maternal age was negative while the effect of previous VBAC was positive 
(OR=0.70 p=0.30, OR=3.28 P =0.22, respectively). The penalized effect estimates are 
given in table 29 alongside the non-penalized estimates; the former are preferred for 
making predictions in new patients (an example is given in the discussion). 
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Effect  βpenalized βnon-penalized 
OR non-penalized 
[95% CI] P value 
Intercept  -0.77 -1.34  0.6256 
Age per 5 year increase -0.29 -0.36 0.70 [0.35-1.37] 0.2957 
RMT per mm increase 1.44 1.83 6.26 [2.12-18.52] 0.0009 
deltaRMT per mm decrease -1.22 -1.39 0.25 [0.13-0.48] <. 0001 
Previous VBAC Yes/no 1.09 1.19 3.28 [0.50-21.47] 0.2157 
 
Table 29: Estimated effects of patient and scar characteristics in fitted 
logistic regression model to predict success of trial of vaginal birth after 
CS 
 
At a cut-off probability of 0.7, the model had values for validated sensitivity and 
specificity of 90% (table 30). The training set AUC for the model was 0.96 (CI 95% 
0.90-0.98) and the internally validated AUC was 0.94 (CI 95% 0.89-0.96). For 
comparison, a reduced model excluding the scar features had a training set AUC of 
0.66 (CI 95% 0.55-0.77) and an internally validated AUC of 0.62 (CI 95% 0.51-0.73).  
 
Cut-­‐off	  for	  
probability	  	   Sensitivity	  	   Specificity	  	  
30	   97 (97) 74 (74) 
50	   95 (94) 83 (81) 
70	   90 (90) 91 (90) 
90	   59 (59) 98 (96) 
 
Table 30. Sensitivity and specificity for success of trial of vaginal birth 
after caesarean section using the prediction model at specified cut-off 
values for predicted probability 
 
 
 
	   103	  
A calibration plot showed the estimated probabilities for successful VBAC given by 
the model to be accurate (Figure 21). There was some underestimation of the 
probability (by 0.1 or less) for predicted probabilities between 0.2 and 0.7, but the 
vast majority of women have predicted probabilities outside this range.  
 
Figure 21: Calibration plot for model to predict success of vaginal birth 
after caesarean section (VBAC), based on patient age, previous history 
of VBAC, residual myometrial thickness and change in RMT between 
first and second trimester, in 121 women with visible caesarean section 
(CS) scar and one previous CS. The vertical lines represent individual 
data points 
 
Clinical usefulness: 
The decision curve for our predictive model is shown in figure 22. The validated net 
benefit, based only on cut-offs of 0.3, 0.5, 0.7 and 0.9, are also shown as bullets. 
The model clearly shows greater net benefit across the range of probability 
thresholds considered, compared with the default strategies. At the cut-off probability 
of 70%, the validated net benefit of the model was 0.45 higher than was that of 
giving none of the women a trial of VBAC. The interpretation of this value is that the 
benefit of using the model with scar characteristics in addition to patient 
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characteristics is equivalent to identifying 45 additional successful VBAC per 100 
patients at the same rate of emergency CS. The model also has clinical utility 
compared to the default strategy of giving all women a trial of VBAC. This was even 
the case at a cut-off of 30%, at which the validated net benefit of the model was 0.11 
higher. This is equivalent to 26 (= 0.11×100/(0.30/0.70)) fewer emergency CS 
deliveries per 100 patients with no increase in the number of unnecessary elective 
CS deliveries. 
 
Figure 22: Decision curves for three strategies: using prediction model (—), 
giving all women a trial of vaginal birth after Cesarean section (VBAC) (········) 
and giving no woman a trial of VBAC (–·–). Validated net benefit, based on 
probability cut-offs of 0.3, 0.5, 0.7 and 0.9, is also shown (•) 
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Discussion:  
We have shown that when sonographic measurements of CS scars during 
pregnancy, namely RMT in the second trimester and change in RMT between the 
first and the second trimesters, are incorporated into prediction models, the success 
of a trial of labour can be predicted with a high level of accuracy. Previously 
published models have focused on single RMT measurements made in the late third 
trimester. In contrast, our study suggests that if an assessment of the scar is made 
relatively early in pregnancy then decisions regarding the mode of delivery can be 
made well in advance of any potential delivery date, hence our decision to examine 
changes in RMT between the first and second trimesters rather than between the 
second and third. 
 
From the clinical information we have obtained, we did not find any factors that 
would confound the view that status of the scar is a major contributor to the 
likelihood of successful trial of VBAC. The failed VBAC group had a tendency to be 
delivered at slightly earlier gestations but also had decreased birth weights. Earlier 
gestation may be a potential contributor to a failed trial of VBAC. Nevertheless this is 
unhelpful in terms of predicting the likely success or otherwise of a trial of labour 
prior to admission for delivery. The differences seen in the failed and successful 
VBAC groups do not negate the high AUC associated with the assessment of the CS 
scar. We cannot provide external proof on these findings in the context of this study. 
External proof of the relative contribution of assessments of scar dimensions and 
change over time will only be provided in the context of a separate study designed to 
externally validate our model.  
 
We found that women who underwent successful trials of labour had significantly 
greater RMT measurements in the second trimester in comparison with women who 
had a failed VBAC. Furthermore, women with a successful VBAC showed minimal 
changes in RMT between the first and second trimesters. It is interesting that it is the 
RMT that seems predictive of outcome rather than the size of the hypoechoic part of 
the scar (the so-called niche or ‘defect’). Our data suggest that even in the presence 
of a large hypoechoic segment, the scar is not necessarily defective as long as the 
RMT is sufficiently thick and remains so during the pregnancy. Moreover, the 
outcome when the scar could not be visualized perhaps supports this, as when a 
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trial of VBAC was attempted in these women, 82% of cases resulted in a successful 
vaginal delivery. We think that an inability to visualize a scar (providing the assumed 
location of the CS scar can be located anatomically) probably reflects good scar 
healing, with no hypoechoic segment on ultrasound. This issue is important, as 
anecdotally we have noticed a trend for clinicians to request assessments of CS 
scars using ultrasound to determine whether they are ‘deficient’. Our findings 
suggest that the observation of a large hypoechoic part of the scar may not indicate 
that scar integrity is compromised in the presence of adequate RMT. 
 
The AUC for our model is perhaps surprisingly high. This may reflect the relatively 
small number of women in the study. However, even if interpreted with caution, the 
findings suggest that the scar is a major factor in the function of the uterus during a 
trial of labor. The main indications for repeat CS in the failed VBAC group were fetal 
distress and failure to progress. It is entirely plausible that both these factors could 
be exacerbated by poor scar healing. There are data to suggest that myometrial 
contractility may be increased in women who have had a CS for fetal distress and 
that this effect is present in future pregnancies 93. The presence of a poorly healed 
scar may impact on decidualisation, subsequent placentation and be associated with 
a greater likelihood of fetal distress in labour. It would seem likely that any degree of 
dehiscence of the scar, even if not reported as such at surgery, would lead to fetal 
distress or compromised myometrial contractility.  
 
There have been several reports describing prediction models to help clinicians 
counsel women regarding the mode of delivery after CS. However to our knowledge 
using a combination of CS scar measurements with clinical variables to predict the 
success or failure of a trial of VBAC has not been described previously. Studies 
published to date have focused on either single RMT measurements at 36 weeks 
gestation 25	   24	   23 or solely on demographic and clinical factors 69. Eden and 
colleagues carried out a systematic review to evaluate VBAC prediction models. 
They concluded that none consistently identified women at risk of a failed trial of 
labour	  69. We have introduced the change in RMT over time as a predictive variable. 
As the uterus changes in size so rapidly during the course of a pregnancy we felt it 
likely that the speed of change in a scar may reflect scar integrity. Our data suggest 
that this may indeed be the case.  
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The studies included in the review by Eden et al. were mainly retrospective, cohort 
and case-control studies. Whilst they contain both antepartum and intrapartum 
variables, none contained information relating to the appearance of the CS scar. A 
strength of our model is that it provides both patient and clinician with a calibrated 
percentage risk for the likely success of a trial of VBAC based on a small number of 
relatively easily identified variables. For example when a 70% cut-off is agreed the 
sensitivity of the reduced (patients characteristics only) variable model was 33% but 
improved to 90% CS scar feature are added (full model). This will limit the need to 
include an exhaustive list of clinical variables.  
 
We can illustrate this by giving two relatively extreme examples. If we consider a 
woman aged 32, without a previous VBAC, with an RMT on her second trimester 
scan of 2.7mm and a decrease in RMT of 1.5mm between the first and second 
trimester. The formula for this example based on the coefficients provided in table 29 
is 1/(1 + exp(-z)), where “exp” refers to the exponential function and z= -0.77 - 
0.29*age/5 + 1.44*RMT – 1.22*deltaRMT + 1.09*previousVBAC. By entering the 
observed values, the chance of successful vaginal delivery for this patient is 36%. In 
contrast, if the same woman had an RMT of 4.1mm at the second trimester 
ultrasound scan and a decrease in RMT of 0.9mm between the first and second 
trimester, she would have a 90% chance of a successful vaginal delivery. There 
were two cases of confirmed uterine rupture in the group selected for a trial of VBAC 
in our study population. If we apply the model in these cases, the predicted chance 
of them achieving a successful VBAC would be 0.00005% and 0.00009% 
respectively. Had the model been applied prospectively both women would have 
been strongly advised against a trial of VBAC and so avoided the morbidity 
associated with uterine rupture.  
 
A key issue for any test is reproducibility. We have shown in study 3.1 above that the 
inter-observer variability for measurement of CS scars is good in the first trimester 
when a single measurement of RMT appears useful, and moderate in the second 
and third trimesters. It is therefore reasonable to suggest that these measurements 
will have utility if used more widely. In terms of clinical convenience, the 
examinations of the scar were timed to coincide with current standard ultrasound 
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scans at around twelve and twenty weeks, so a scar assessment will not increase 
the number of visits required in the antenatal period.  
 
It is important to emphasize that the prediction model described in this paper has not 
undergone external validation, this is an essential step before we can conclude that 
incorporating scar measurements into prediction models is generalizable and so has 
clinical utility. Furthermore the study was conducted on a relatively small sample 
size, and this may also explain the relatively small effect of a previous history of 
VBAC in the multivariate model.  
 
A further issue to consider is that whilst we have included both demographic and 
previous obstetric history into the model, we have not included more detailed 
information about previous deliveries. Such information would have been 
retrospective and we would have not been able to be certain of its accuracy. Another 
point to consider is the 47 cases that ended with failed trials of labour. In this group 
an emergency CS was performed on 7 cases based on a clinical picture of uterine 
scar rupture, which was subsequently confirmed in 2 out of 7 cases. The remaining 
40 cases developed signs of fetal compromise secondary to failure in the progress of 
labour. It is difficult to judge whether the old CS scar had a role in the failed trial of 
labour in these 40 cases, as no documentation was available in the clinical notes 
apart from the commonly used term ‘failure to progress’. Therefore, we did not 
include clinical findings at the time of admission for delivery, as our aim was to 
produce a prediction model to enable decisions to be made in advance of the likely 
date of delivery. However including some of this extra information in future studies 
may enhance model performance further.  
 
Despite attempts to stem the tide, CS rates globally are relatively high. As a result 
the number of women approaching their second pregnancy with a scar on the uterus 
is increasing cumulatively. Consequently, establishing reliable ways to advise this 
group of women on the likelihood of them succeeding in a future trial of labour is of 
increasing importance. We have shown that information about a CS scar derived 
using ultrasound when included in a prediction model can give an accurate 
quantitative assessment of the likelihood of vaginal delivery after a previous CS. If 
test performance is retained on external validation, this “scar based” approach to 
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advising women contemplating a trial of VBAC could allow women to make well-
informed decisions about their options for delivery relatively early in the course of 
their pregnancy. 
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Summary 
The CS rate varies from approximately 20 to 50% depending on the country and 
clinical environment. The result is that more women are becoming pregnant with a 
scar on the uterus. Therefore any problems associated with the presence of a CS 
scar are potentially significant both for individual patients as well as at a societal 
level. Ultrasound offers a non-invasive approach to visualising the uterus and any 
scar present, and the use of ultrasound in this context has already attracted 
significant interest in the literature. However prior to further investigating the 
morphology or the size of CS scars as possible markers of scar integrity, it is 
essential to establish standardised and reproducible methods for both describing 
and measuring CS scars in the pregnant state. Furthermore the tendency to 
describe the ultrasound features of scars as “deficient” inevitably leads the reader to 
conclude that “deficient” relates to function and not just appearance. A CS scar may 
appear hyperechoic and cystic using ultrasonography, but how can it be called 
“deficient”? Our view is that an alternative terminology should be developed, and that 
the morphology of a CS scar should be described on the basis of objective 
measurements and in descriptive ultrasound terms only. 
Suboptimal healing of a CS scar has become one of the recognised complications 
associated with this type of operation. The exact cause and mechanism of this 
condition is not well understood. As more women undergo transvaginal 
ultrasonography, the morphology of section scars has come under increasing 
scrutiny. Currently it is not known if the appearances of these scars using ultrasound 
relate to the functional integrity of the uterus, the risk of scar ectopic pregnancy, 
pathological placentation, uterine rupture or performance in labour. There is an 
urgent need to explore this relationship so that we can understand how to interpret 
images of a uterus with caesarean section scar and the implications of various types 
of scar on patient management.  
Studying the natural history of CS scars in pregnancy is important as certain scar 
features and how they change over the course of pregnancy may provide important 
information when considering either a trial of vaginal delivery or a repeat caesarean 
delivery. Furthermore the incorporation of such ultrasound features into scoring 
systems or models to predict successful VBAC may refine decision making further. 
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Uterine scar rupture is a rare event, yet its consequences can be dramatic. On the 
other hand, scar dehiscence, poor performance in labour, menstrual problems and 
scar pregnancy are also important secondary outcome measures to consider. 	  
From these prospective study we can summarise the findings as follows: 	  
• I have presented an overview of ultrasound-based definitions and methods 
used to describe CS scars as well as information relating to the performance 
of alternative techniques used to evaluate CS scars. Having examined the 
current evidence a standardized approach to describe CS scars using 
ultrasound-based definitions was proposed. 
• CS scars remain visible in the majority of women throughout pregnancy. They 
can be reproducibly measured in three dimensions when assessed by TVS in 
all trimesters of pregnancy. The agreement between two observers for CS 
scar measurement can be considered good for the first trimester, compared 
with relatively moderate agreement for the second and third trimesters. 
• Previous CS increases the risk of vaginal bleeding in early subsequent 
pregnancies. The implantation site in women with CS is more likely to be 
posterior and its distance to the internal cervical os shorter. Implantation close 
to or covering the scar increases the risk of spontaneous miscarriage. 
Implantation crossing the scar may occur and care must be taken before 
diagnosing CS scar pregnancy.  
• The presence of CS scars in the uterus is associated with an increase in the 
number of posterior placentae and a reduced number that implant in the 
fundus of the cavity. Migration of a low-lying placenta is independent of the 
presence of a CS scar in the uterus. 
• We established reference data and confirmed that CS scars change in 
dimension throughout pregnancy. Scar rupture was associated with a smaller 
RMT and greater decrease in RMT during pregnancy. Both single 
measurements and changes throughout the course of the pregnancy 
significantly affect scar appearance at repeat CS, and RMT appears to have a 
strong predictive value for scar appearance at repeat caesarean delivery from 
as early as 20 weeks gestation.  
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• The absolute value and changes seen in CS scars have the potential to be 
tested as predictors of uterine scar rupture and performance in trials of VBAC, 
and ultrasound measurements of the CS scar, expressed as RMT and the 
change in RMT between the first and the second trimester of pregnancy, 
when incorporated into a mathematical model, may accurately predict a 
successful trial of labour in patients with one previous CS, although it must be 
emphasised that external validation of this approach is still needed. 
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